CN101896140B - Devices and methods for treating spinal cord tissue - Google Patents

Devices and methods for treating spinal cord tissue Download PDF

Info

Publication number
CN101896140B
CN101896140B CN200880121075.8A CN200880121075A CN101896140B CN 101896140 B CN101896140 B CN 101896140B CN 200880121075 A CN200880121075 A CN 200880121075A CN 101896140 B CN101896140 B CN 101896140B
Authority
CN
China
Prior art keywords
bond material
multiporous biological
spinal cord
damage
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200880121075.8A
Other languages
Chinese (zh)
Other versions
CN101896140A (en
Inventor
L·C·阿金塔
D·L·凯罗
N·H·利瓦伊
刘杰
M·J·莫里夸斯
S·塔特
W·D·沃纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wake Forest University Health Sciences
Original Assignee
Wake Forest University Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wake Forest University Health Sciences filed Critical Wake Forest University Health Sciences
Publication of CN101896140A publication Critical patent/CN101896140A/en
Application granted granted Critical
Publication of CN101896140B publication Critical patent/CN101896140B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/91Suction aspects of the dressing
    • A61M1/916Suction aspects of the dressing specially adapted for deep wounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61F13/01021
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/71Suction drainage systems
    • A61M1/74Suction control
    • A61M1/75Intermittent or pulsating suction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/91Suction aspects of the dressing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/90Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
    • A61M1/96Suction control thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/10Trunk
    • A61M2210/1003Spinal column

Abstract

The present invention provides devices and methods that treat damaged spinal cord tissue, such as spinal tissue damaged by disease, infection, or trauma, which may lead to the presence of swelling, compression, and compromised blood flow secondary to interstitial edema.

Description

The apparatus and method that are used for the treatment of myeloid tissue
Invention field
The present invention relates generally to the apparatus and method of the myeloid tissue that adopts negative pressure treatment damage or infringement, and more particularly, but be not exclusively, relate to being used for the treatment of to experience and can recover or the apparatus and method of the myeloid tissue of irrecoverability damage.
Background of invention
The treatment of the myeloid tissue that relates to anatomy, physiology and the pathological process special concern damage of spinal cord attitude or damage.The three dimensional structure anatomy of neuroprotective unit (its function depends on the special space relation with other neuron and other sustenticular cell) concern both with microanatomy and maintain suitable oxygen enrichment blood flow and wherein the homogeneous phase substrate of neuronal survival be myeloid tissue survive and function necessary.In addition, cord cell can not be regenerated and given prominence to for making each possible neuronic survival reach demand to greatest extent.Due to for example these reasons, the space sickness Neo-Confucianism for the treatment of spinal cord attitude open and closed system is the problem of special concern.
In the clinical problem that threatens myeloid tissue's survival is arranged, it is main controlling edema of spinal cord, infection and blood supply.Spinal cord responds to wound and damage by the interstitial edema of collecting significant quantity.Because spinal cord is closed in the space (dura mater and ridge pipe) of sealing, the blood flow that edema causes spinal cord is with the compression of performance nutrition and weaken, and this physiology that damages widely spinal cord recovers and usually therefore cause the development and death of spinal cord lesion.Comprise medicine for reducing the current available treatment of edema, for example glucocorticoid (dexamethasone, prednisone, methylprednisolone), diuretic and decompression widely.Yet, for the unfavorable conditions of these treatments, comprise irregular and unpredictable results, medicine complication, infection and postoperative complication.
Due to disastrous consequence and the high likelihood of spinal cord infection with the fast propagation of edema, to demand quick and that effectively treat, be also extremely important.There is at present the successful methods of the pathological changes of several available treatment invasion and attack spinal column inner chambers, spinal cord essence and surrounding structure.When organizing of health other places is available, change dressings while processing, spinal cord is because its unsettled structure, the potentiality that infect tendency and lesion development are not suitable for the type treatment.Illustrate on evidence the inflammation of spinal cord injury and other pathological changes and immunne response are had with initial damage or injure identical or than initial damage or the more long-term consequence of injury.Spinal cord causes the damage of hypoxia and the mediation of local ischemia/reperfusion to replying of the Oligemia that is secondary to edema.These damages cause neuro pathology's sequela, and the latter causes again the unfavorable result of spinal cord injury to a great extent.
In addition, spinal cord need to continuously be supplied with the oxygen enrichment blood flow with performance function and survival.Interrupting blood flow to spinal cord fully in a few minutes, cause irreversible spinal cord injury.Yet, spinal cord can survive and the blood flow that certainly reduces in recover the period more extended.The focus zone (focal areas) that spinal cord is described on evidence can keep ischemia with relative nonfunctional a couple of days and still can recover.This discovery has caused the concept in ischemia zone, is called penumbra Huo Yun district (halo zone), and it is around the zone of irreversible damage.The secondary phenomenon in ischemia zone (secondary phenomena) is to discharge by the local excitatory neuron toxin discharged of the neuron of damage, variation and the edema of focal zone blood flow.
The angiological pathology of spinal column can be following result: because perfusion pressure reduces, cause the angiorrhexis to local spinal cord zone coup injury, or make to flow to the hematopenia of cord cell by compressing adjacent tissue; Such as atherosclerosis, aneurysm, inflammation etc. of spinovascular intrinsic disease; From other places for example heart be deposited on the sparse thrombosis in the spinal cord blood vessel.
In the situation that the spinal column internal hemorrhage, the hemorrhage fritter material usually used as dissect the volume growth of (pressure dissection) with pressure starts and causes the myeloid tissue of displacement and compressing vicinity.Edema in the hemorrhage oppressed tissue of vicinity on every side can cause by the more large-area myeloid tissue of infringement the deterioration of mass effect and clinical condition.Edema in contiguous spinal cord can cause usually through the deterioration of 12-72 hour visible carrying out property.Edema occurs in one week after the spinal column internal hemorrhage and usually make prognosis become even worse, especially in aging people.Perihematoma organize replaced and compressing, but not necessarily fatal infringement.Improvement can be absorbed due to hematoma again, contiguous decrease in edema and the organized renewing function of getting involved obtain.
Treat these diseases and made people's disappointment.It may be useful that the decompression of spinal cord prevents in the case of irreversible compressing at some.Reagent for example other penetrating agent of mannitol and some can reduce the spinal column internal pressure caused by edema.Steroid has uncertain value in these cases and current built view adopts hyperbaric oxygen.
Therefore, although to injured skin and subcutaneous tissue apply negative pressure (or negative pressure) therapy confirm with traditional method relatively Healing Rate increase and (set forth in No. the 2003/0225347th, 2004/0039391 and 2004/0122434, No. the 5645081st, 5636643,7198046 and 7216651, US patent and the disclosed application of US, its content is attached to herein by reference), still need to be specially adapted to the apparatus and method of special myeloid tissue.
Summary of the invention
The invention provides the myeloid tissue that adopts negative pressure (or negative pressure) treatment damage, for example, by the apparatus and method of the myeloid tissue of disease, infection or wound infringement, described disease, infection or wound can cause being secondary to the existence of blood flow of swelling, compressing and the minimizing of interstitial edema.For example, spinal cord can be by causing recovering or the blunt force injury damage of expendable damage.
In one aspect, the invention provides the method for the myeloid tissue that adopts the negative pressure treatment damage.The method comprises porous material is placed in to approach between the myeloid tissue of myeloid tissue with the one or more holes at porous material and damage of damaging provides gas communication (gaseouscommunication).Porous material can be sealed in the myeloid tissue that approaches damage on the spot, so that the zone of the myeloid tissue's maintenance negative pressure that maintains damage to be provided around the myeloid tissue in damage.Porous material can be connected by the vacuum system that operationally with myeloid tissue in damage, produces negative pressure, and the vacuum system started provides negative pressure in the myeloid tissue of damage.Can in the myeloid tissue of damage, keep negative pressure to be enough to reduce at spinal cord the time of edema.For example, negative pressure can remain on lower than the about 25mm Hg of atmospheric pressure.The method also can be included in the myeloid tissue of damage settles protective layer seal protection layer in the tissue of the myeloid tissue that approaches damage, for the myeloid tissue in damage, keeps negative pressure.The form that protective layer can be placed in the autoadhesion sheet (self-adhesive sheet) in the myeloid tissue of damage provides.In such a case, the step of seal protection layer can comprise and seal deadlockedly and make the autoadhesion sheet adhere to the tissue around the Spinal Cord tissue, between described and tissue around the myeloid tissue of damage, to form sealing.
In yet another aspect, the invention provides the device that is used for the treatment of the Spinal Cord tissue.But this device can comprise the biology bond material of porous for example opens chamber (open-cell) collagen protein, it has the pore structure that is shaped to allow carry out gas communication between one or more holes of porous material and the myeloid tissue for the treatment of.The biological combinableness matter of porous material can avoid needing second method to remove porous material.(as used herein term " biological combinative " be defined as describing can be positioned over for a long time in patient body and can be by refigure, the material reuptaking, dissolve and/or otherwise assimilate or modify).Device also comprises the vacuum source for generation of negative pressure; Vacuum source can be configured for the distribution negative pressure to myeloid tissue with the mode of the gas communication of porous material.Porous material at least can have on the surface of the selection of porous material enough little hole to prevent from being organized in wherein growth.In addition, porous material at least can have the pore size that is less than fibroblast and cord cell size on the surface of the selection of porous material, and can have in the position except selected surface the pore size that is greater than fibroblast and cord cell size.The pore size of porous material can be even as big as the protein motion that allows the albumin size to pass through.And, but the biology bond material of porous can comprise at least one sealed surface to prevent that negative pressure from therefrom transmitting.Device also can comprise the protective layer in the myeloid tissue that is shaped to cover damage, under the protective layer at the Spinal Cord tissue, to keep negative pressure.
Therefore, the progress the invention provides for making pathological process reduces to minimum, makes the destruction of physiology spinal cord integrity reduce to minimum and make the interference of spinal cord blood flow and nutrition is reduced to minimum apparatus and method.By reducing edema of spinal cord and spinal column internal pressure, the risk that spinal cord forms hernia and infringement can be reduced to minimum.In addition, the present invention is convenient to remove the toxin that in medium, catabolite and enhancing spinal cord, the neuro pathology of inflammation and tissue replys.
The accompanying drawing summary
When read in conjunction with the accompanying drawings, above-mentioned general introduction and the following detailed description of the preferred embodiments of the invention will get the best understanding, wherein:
Fig. 1 illustrates the partial sectional view of the example arrangement of apparatus of the present invention before applying negative pressure on the spot;
Fig. 2 illustrates the partial sectional view of Fig. 1 when applying negative pressure;
Fig. 3 illustrates and is presented at the partial sectional view of Fig. 1 and 2 that the spinal cord surrounding tissue applies the effect of negative pressure;
Fig. 4 illustrates and comprises on the spot the subcutaneous partial sectional view that is configured in second example arrangement of the present invention of epispinal rigidity or semi-rigid protective layer;
Fig. 5 illustrates and comprises on the spot the subcutaneous partial sectional view that is configured in the 3rd example arrangement of the present invention of epispinal flexible protective layer;
Fig. 6 for example understands that the BBB scoring is as the time function that is exposed to the control animal of recoverable spinal cord blunt wound;
Fig. 7 for example understands the time function of BBB scoring as the animal that is exposed to recoverable spinal cord blunt wound and processes by negative pressure;
Fig. 8 for example understands the spinal cord sectional area as the time function of the control animal that is exposed to expendable spinal cord blunt wound;
Fig. 9 for example understands the spinal cord sectional area as the time function of the animal that is exposed to expendable spinal cord blunt wound and processes by negative pressure; With
Figure 10 illustrates the porous material had for the multiple structure of negative pressure device of the present invention.
Detailed Description Of The Invention
While mentioning accompanying drawing now, wherein same parts adopt identical numbering in the text, the present invention relates to adopt the apparatus and method of the myeloid tissue of negative pressure (or negative pressure) treatment damage, wherein " damage " tissue be defined as comprising be damaged, damage or with any alternate manner weakening for example due to the tissue of wound, disease, infection, postoperative complication or the damage that for example other pathological process causes.More particularly, apparatus and method of the present invention can realize more than any reason for example mentioning the treatment of the Secondary cases spinal cord essence edema of reason; Around spinal cord, any gap comprises the treatment of subdural space/epidural space; With the treatment raise due to any reason spinal column internal pressure that for example above-mentioned reason causes.
The example arrangement of negative pressure medullotherapy device 100 of the present invention can comprise for the vacuum source 30 of negative pressure, Fig. 1-3 are provided to the porous material 10 that is arranged in contiguous spinal cord 7 by pipeline 20.In this respect, can construct porous material 10 to transmit and the distribution negative pressure to spinal cord 7.Medullotherapy device 100 can be applied to the patient by the myeloid tissue 7 that porous material 10 is placed in to contiguous damage, between the myeloid tissue 7 with the one or more holes at porous material 10 and damage, provides gas communication.Pipeline 20 can be connected in porous material 10 at the far-end 22 of pipeline 20, and porous material 10 can seal on the spot by the stitching thread 8 in skin and subcutaneous tissue 2, around the myeloid tissue 7 in damage, to provide a zone for keeping negative pressure.The near-end 24 of pipeline 20 can be connected to vacuum source 30 with porous material 10 and the vacuum source 30 of being operably connected, and for the myeloid tissue 7 in damage when starting vacuum system 30, produces negative pressure.
Forward more detailed Fig. 1 to, patient's surrounding tissue that the example arrangement of negative pressure medullotherapy device 100 of the present invention shows at partial sectional view is illustrated on the spot.The tissue of example explanation comprises skin and subcutaneous tissue 2, muscular tissue for example trapezius muscle 3 and erector spinae 4, vertebra 5, transverse process 6 and spinal cord 7.To lead to spinal cord 7 in order providing, can to lack a part of vertebra 5.For example, spinous process can lack due to operation dissection, disease or damage.Porous material 10 is for example opened the subcutaneous space that the chamber collagen material for example can be placed in the contiguous myeloid tissue 7 with negative pressure treatment, with the edema that reduces parenchymal tissue with improve physiological function.Except opening the chamber collagen material, porous material 10 also can comprise polyglycolic acid and/or poly-lactic acid material, synthetic polymer, flexible sheets sample sieve aperture, open the chamber foam of polymers, foam segment, porous chips, polyvinyl alcohol foam, polyethylene and/or polyester material, elastin laminin, hyaluronic acid, alginate, polyglycols citron acid esters, poly butyric ester, poly-hydroxyfumaric acid ester, PTMC, polyglycereol sebacate (sebecate), the poly-anhydride of aliphatic/aromatics or other suitable material, and for example can pass through electrospinning (electropinning), the combination of any above-mentioned material of casting or printing preparation.Such material comprises chitosan solution (1.33% weight/volume in 2% acetic acid, 20ml cumulative volume), and it can be poured in the mould of suitable size.Then make solution under-70 ℃ freezing 2 hours, then be transferred in lyophil apparatus and apply vacuum 24 hours.Described material can, by 2.5%-5% glutaraldehyde steam crosslinked 12-24 hour (or passing through ultraviolet radiation 8 hours), provide casting porous material 10.
In addition, porous material 10 can be by casting polycaprolactone (PCL) preparation.The chloroform that polycaprolactone can mix with sodium chloride (1 part of caprolactone is to 10 parts of sodium chloride) and be placed in enough volumes is with dissolved constituent.For example, the solution of 8ml can be poured in the container of suitable size and shape and make it dry 12 hours.Then can make sodium chloride leach in water 24 hours.
Also can use the electrospinning material for porous material 10.It for the preparation of the preparation of electrospinning porous material 10 and an illustration of method, is the Collagen type I adopted with the ratio existence of 76%: 4%: 20% (weight): ch.-6-s (CS): the combination of poly-1,8-ethohexadiol citron acid esters (POC).Two kinds of solvents are for collagen/CS/POC.Make CS soluble in water and collagen and POC are dissolved in 2,2,2-trifluoroethanol (TFE).Then use the solution of 20% water/80%TFE solution (volume/volume).For electrospinning, will contain collagen: CS: the solution of POC mixture is placed in the 3ml syringe that is equipped with the 18Ga pin.Syringe pump (New Era Pump Systems, Wantaugh, NY) is for being delivered to the pin end by solution with the speed of 2.0ml/hr.10-20kV voltage is provided and is applied to distance between the pin of 15-25cm (anode) and ground connection catcher (negative electrode) through high voltage power supply (HV PowerSupply, Gamma High Voltage Research, Ormond Beach.FL).Then make the crosslinked and thermal polymerization (80 ℃) of this material and glutaraldehyde (II level, 25% solution) 48 hours.Also can the initial concentration in HFIP (HFP) be 80mg/ml collagen starts electrospinning Collagen type I porous material 10, then adopt and combine identical electrospinning condition with collagen: CS: POC.
A kind of other method for generation of porous material 10 is to adopt the thermal inkjet-printing technology.But biology bond material for example collagen, elastomer, hyaluronic acid, alginate and polylactic acid/polyglycolic acid copolymer can be printed.For example, be dissolved in 0.05% acetic acid, then be diluted with water to type i collagen (the Elastin Products Co. of 1mg/ml, Owensville, MO) can be printed, as sodium alginate (Dharma Trading Co., San Raphael, CA) 1mg/ml is printable the same in water.Type i collagen (2.86mg/ml is in 0.05% acetic acid) and polylactic acid/polyglycolic acid (PURAC America, Blair, NE) (14.29mg/ml is (SigmaAldrich, St.Louis MO) in tetraethylene glycol (TEG)) also can be printed.Comprise motor and can be installed in platform for the spool bed (carriage) of ink powder tube (cartridges) from the hardware of Hewlett Packard 660c printer.Then the height of capable of regulating hardware more than platform printed for layering.
Porous material 10 can comprise enough little hole in the interface between porous material 10 and spinal cord 7, and to prevent from being organized in wherein growth, for example pore size is less than the size of fibroblast and cord cell; Otherwise porous material 10 can adhere to spinal cord 7 and cause bleeding when removing porous material 10 or wound.In addition, the pore size on interface between porous material 10 and spinal cord 7 can be enough little, in order to avoid excessively producing granulation or scar tissue on spinal cord 7, granulation or scar tissue can disturb the physiological function of spinal cord 7.Simultaneously, the pore size of porous material 10 can must be enough to greatly the protein motion that allows the albumin size to pass through, for example, to allow to remove undesirable compound, medium, catabolite and toxin.
For example, yet porous material 10 can or have larger pore size (being greater than the size of fibroblast and cord cell) in any other position of the porous material 10 do not contacted with myeloid tissue 7 in the inside of porous material 10.For example, porous material 110 can comprise the multiple structure with non-inside grown layer (non-ingrowth layer) 112, it has enough little pore size and wherein grows and alternative spinal cord to prevent from being organized in, and can there is the additional layer 114 of different materials, it has the relative larger pore size with non-inside grown layer 112 contacts.
Perhaps, porous material 10 can be uniform aspect composition and/or morphology.Position at the interface away from spinal cord 7, porous material 10 can have the pore size that promotes to form granulation tissue even as big as other tissue in the surrounding space at spinal cord 7, and the zone promotion formation granulation tissue that spinal cord breaks for example occurs.In addition, it is sealed in case stop-pass is crossed the surface transmission negative pressure of such sealing that porous material 10 can have one or more sides or the surface of porous material 10 wherein, and have the structure on the surface that at least one can be by its transmission negative pressure simultaneously.Can there be the tissue of priority treatment in such structure of porous material 10 and process other side in a side of porous material 10.For example, non-tight interface processing when, the essence of spinal cord 7 can be with a side of porous material 10.
Porous material 10 can comprise the material that need to remove after giving negative pressure therapy, and it can need second operation.Perhaps, but porous material 10 for example can comprise elapsed time bio-absorbable or harmless degraded, to avoid the material of second operation, collagen.In addition, porous material 10 can comprise nonmetallic materials, in order to can implement MRI simultaneously porous material 10 on original position.If porous material 10 also can comprise the material of enough compliances so that it compresses spinal cord 7, porous material 10 does not affect spinal function.Simultaneously, porous material 10 can comprise enough solid material, so that porous material 10 does not collapse to the degree that generation can affect stretching or the distortion " normal spinal cord " of spinal function.
In order to porous material 10, to transmit negative pressure to be distributed to spinal cord 7, pipeline 20 can be connected with the mode of porous material 10 with gas communication directly or indirectly at the far-end 22 of pipeline 20.For example, the far-end 22 of pipeline 20 can be embedded in porous material 10 or can be placed on porous material 10.The far-end 22 of pipeline 20 also can comprise one or more perforation to help to porous material 10 and spinal cord 7 transmission negative pressure.Pipeline 20 can extend by the opening in skin and subcutaneous tissue 2, and its available stitching thread 8 provides sealing around being fixed on pipeline 20 around pipeline 20 with help.The near-end 24 of pipeline 20 can be operably connected to vacuum source 30, and vacuum pump for example, to provide the negative pressure to porous material 10 and spinal cord 7 transmission by pipeline 20.
Vacuum source 30 can comprise controller 32 to regulate the generation of negative pressure.For example, vacuum source 30 can be shaped to produce continuously or off and on negative pressure; For example vacuum source 30 can circulate to provide the alternate cycles that produces and do not produce negative pressure by spells.Buty cycle between producing and not producing can be between 1:10 (ON/OFF)-10:1 (ON/OFF).In addition, intermittently negative pressure can through periodicity or cyclicity waveform for example sine wave apply.Vacuum source 30 can be circulated in initial treatment after simulating more physiological status, for example several times per minute.Negative pressure can circulate off and on when needed as the piezometry through monitoring spinal cord 7.Usually, vacuum source 30 can be shaped to transmit negative pressure at atmospheric pressure and between lower than atmospheric pressure 75mm Hg, so that negative pressure can cause hemorrhagely entering spinal cord 7 or opposing that mutually chance that spinal cord 7 is harmful reduces to minimum.Can handle and apply such negative pressure from spinal cord 7, to remove edema, so the neuroprotective function is to increase the probability of more Physiological protection recovering state and survival.
In order to contribute to keep the negative pressure of spinal cord 7, can provide flexible protective layer/sheet 50 or rigidity (or semi-rigid) protective layer 40 approaching spinal cord 7 places, so that a zone that can keep negative pressure, Fig. 4,5 to be provided around spinal cord 7.Specifically, with reference to Figure 4 and 5, the zone 48,58 of tissue to seal in spinal cord 7 and restriction around porous material 10 that approaches spinal cord 7 by protective layer 40,50 is adhered to can provide protective layer 40,50 on spinal cord 7 and porous material 10.For example, protective layer 40,50 can adopt binding agent 42 for example Fibrin Glue adhered to vertebra 5, muscular tissue 4 and/or other suitable tissue.Binding agent 42 can comprise autohemagglutination rubber alloy (auto-polymerizing glue) and/or can desirably comprise filler, so that the binding agent 42 with enough volumes to be provided, so that binding agent 42 can meet the shape of the potential irregular surface of binding agent 42 contacts.Binding agent 42 can be used as component separately or provides as the part of protective layer 40,50, so that half gluing protective layer 40,50 to be provided.For example, protective layer 50 can comprise flexible half sheet adhesive, and it comprises suitable binding agent on its one or more surfaces.
For flexible protective layer 50, the outward flange of flexible protective layer 50 or edge can twist in spinal cord 7 times (or to) spinal cord 7 is rolled.Perhaps, but flexible protective layer 50 rolling off spinal cord 7, so that then following (side is facing to the porous material 10) of protective layer 50 can contact with muscle and soft tissue on every side with vertebra 5, Fig. 5.If flexible protective layer 50 is rolled for 7 times at spinal cord, binding agent 52 can be coated on the outside of the protective layer 50 between protective layer 50 and vertebra 5, muscle and soft tissue on every side so, to help to promote gas-tight seal.If flexible protective layer rolling off spinal cord 7, binding agent can be applied to the following of protective layer 50 between protective layer 50 and vertebra 5 and on every side muscle and soft tissue to produce gas-tight seal.
Negative pressure can the transmission of the cooperation between protective layer 40,50 and pipeline 20 below protective layer 40,50.Specifically, protective layer 40 (or flexible protective layer 50) can comprise the vacuum valve 43 be connected with the far-end 22 of pipeline 20, so that the gas communication between pipeline 20 and the space 48 above the following spinal cord 7 of protective layer 40, Fig. 7 to be provided.Perhaps, protective layer 50 (or protective layer 40) can comprise the path 52 that pipeline 20 passes through so that the far-end 22 of pipeline 20 is configured in below protective layer 50 in the space 58 above spinal cord 7 and with space 58 gas communications, Fig. 5.
Protective layer 40,50 can be used for further limiting spinal cord 7 subcutaneous area on every side that keeps negative pressure.As graphic extension in Figure 4 and 5; protective layer 40,50 provides the space of sealing/ zone 48,58 around spinal cord 7 below protective layer 40,50, and it can be used for separating tissues and is not exposed in the outside of protective layer 40,50 negative pressure that imposes on spinal cord 7.On the contrary; as graphic extension in Fig. 2 and 3; in unprotected situation; be transferred to porous material 10 and can inwardly towards pipeline 20 and porous material 10, attract surrounding tissue along the direction of arrow shown with the negative pressure of spinal cord 7 in Fig. 2; for example muscle 3,4, cause the organizational structure that diagram shows in Fig. 3.In this respect, stretch and/or moving tissue for example muscle 3,4 can help applied negative pressure is limited to the zone between muscle 4 and spinal cord 7.In addition, protective layer 40,50 can further protect spinal cord 7 that the exogenous infection that can't protect and the pollution that are provided by porous material 10 and the skin 2 sewed up are provided.Equally, protective layer 40,50 can further protect surrounding tissue to avoid the infection diffusion that for example spinal cord abscess, meningitis and myeloid tissue infect from spinal cord 7.
Aspect its another, the present invention also provide for by for example at the device of Fig. 1-5 graphic extension, adopt the method for the myeloid tissue of negative pressure treatment damage.Specifically, method can comprise the myeloid tissue 7 that porous material 10 is placed in to approaching damage, between the myeloid tissue 7 with the one or more holes at porous material 10 and damage, provides gas communication.Porous material 10 can be sealed on the spot in the myeloid tissue 7 that approaches damage, with the zone that provides for the myeloid tissue 7 in damage, to keep negative pressure around the myeloid tissue 7 in damage.In this respect, but muscle 3,4 and subcutaneous tissue loosely the top of porous material 10 with by skin 2 with sew up the pipeline 20 that the skin 2 of sealing leaves away and reaccees.The dressing of another gas-tight seal can optionally be placed in suture location to promote gas-tight seal.Porous material 10 can be operably connected to vacuum system 30, for the myeloid tissue 7 in damage, produces negative pressure, and vacuum system 30 is actuated to provide negative pressure in the myeloid tissue 7 of damage.For example, negative pressure can be maintained at about the Hg lower than atmospheric pressure 25-75mm.The time that the myeloid tissue 7 that negative pressure can be maintained at damage is enough to reduce the edema of spinal cord 7 or controls the spinal fluid seepage.In addition, the myeloid tissue 7 that negative pressure can be maintained at damage is enough to regulate the time of myeloid tissue 7, and the stage reduced to reach recovery from illness and antibacterial numeration for example, can be successfully so that accept Retreatment (lobe (flaps), skin transplantation).Method can be used at least 4 hours, or can use many days.When vacuum-therapy finishes, can remove stitching thread 8 and make skin 2 opening again.Then can remove porous material 10 and again sew up sealing skin 2.
Method also can comprise that the tissue that is placed in above the myeloid tissue 7 of damage by protective layer 40,50 and protective layer 40,50 is sealed in to the myeloid tissue 7 that approaches damage keeps negative pressure for the myeloid tissue 7 in damage.The step that protective layer 40,50 is sealed in to the tissue around the myeloid tissue 7 of damage can comprise by protective layer 40,50 deadlocked seal and adhere to the tissue around the myeloid tissue 7 of damage.Protective layer 50 can provide from the form of attachment flaps (self-adhesive sheet) 50, and it can be positioned at above the myeloid tissue 7 of damage.In such a case, the step of seal protection layer 50 can comprise by from attachment flaps 50 deadlocked seal and adhere to the tissue around the myeloid tissue 7 of damage, between the tissue around the myeloid tissue 7 of sheet 50 and damage, to form and to seal.In addition, operationally with the form of gas communication, connect vacuum system 30 and can comprise with the step of porous material 10 vacuum valve 42 that is connected vacuum system 30 and protective layer 40.
Embodiment
Spinal Cord Injury in Rats and negative pressure expose
Experiment 1
Implement series of experiments and rat is dampened to the effect of the rear spinal cord of damage to determine negative pressure.In first animal scheme, obtain 250-300 gram Sprague Dawley rat and set up contusion of spinal cord model and confirmation.Produce the method for damaging and estimate recovery and be based on Wrathall etc., the contusion of spinal cord damage of rat: classification, can repeat, the generation of damage group, experimental neurology (Spinal Cord Contusion in the Rat:Production of Graded, Reproducible, Injury Groups, Experimental Neurology 88,108-122 (1985)) description of contusion of spinal cord damage in.The development surgical technic is for the spinal cord that exposes anesthetized rat and lean on body by the circle that falls 10 gram weight through glass tubing from 5cm height and produce consistently and dampen damage.The half rat is untreated matched group, and second half have be exposed to 4 hours negative pressure (lower than atmospheric pressure 25mm Hg) the contusion zone.Yet the degree of damage does not produce remarkable damage (they recover rapidly) in control animal, and therefore can not compare treatment group animal and control animals.
Experiment 2
Set up second scheme, wherein on spinal cord, suffer more serious damage (10 gram weight fall from higher height-7.5cm).28 large (300 gram) Sprague Dawley rats are purchased a period of time and are made it to adapt to the condition of supporting of closing.On operation same day, make animal calm and scrape hair at its back and clean with for operation.Make the midline incision for preparing through spinal column extend and expose darker muscle of back with fascia by skin and subcutaneous tissue and the large flesh of skin (maximus muscle).Be located away from center line paired muscle the offside retraction (retracted laterally) that center line (trapezius muscle and hiding latissimus dorsi m.) is joined.Deep ' posture ' muscle for example is connected to ridge oblique (spinotrapezius) and/or the erector spinae (sacrospinal) itself of spinal bone structure and also retracts at center devision offside.This has exposed spinous process and some hiding transverse process.In the T7-T9 level, remove spinous process between two continuous vertebras and little transversospinales, expose spinal cord surface (dura mater).Implement laminectomy at T-8.Method based on Wrathall etc., make spinal stabilization at T-7 and T-9 and highly fall 10 gram weight to produce moderate spinal cord injury from 7.5cm.5 animals died from respectively its initial operation same day (3 matched group and 2 in the vacuum-therapy group), and 1 animal dead in the early stage matched group of experiment, entered latter 2 days remaining 22 animals of experiment.While finishing to experiment, 11 animals have been randomized to either each group in matched group and 25mm Hg vacuum group.
For control rats, do not provide treatment, and damage is sewn sealing.For vacuum-therapy group rat, polyvinyl alcohol vacuum pack system (Vacuseal Plus, Polymedics, Belgium) is placed on spinal cord and skin is sewn sealing, and vacuum tube passes through incision extension.After within 1 day, postponing, to each animal of vacuum-therapy group, apply lower than the vacuum (negative pressure) of atmospheric pressure 25mm Hg 4 hours.When this time finishes, make animal again calm, remove vacuum pack system, and skin incision is sewed up again with monofilament linea suturalis.
Check cutting part every day.Check that animal self drains the sign of its bladder capacity.Any animal that can not drain is accepted manual auxiliary facilities 3 times with 8 hours intervals every day.Check autophagy metabolism (auto-cannibalism), decubital ulcer and the degree of hydration (squeezing test (pinchtest)) of animal every day.Animal is closed to be supported in soft sized (soft shavings) so that the probability of decubital ulcer development reduces to minimum.Food is placed in the cage bottom so that edible.Animal is checked the recovery of hind leg motor function every day, and each hind leg is adopted to improved Tarlov marking system, and (0=is without motion, without load-bearing; The 1=light exercise, without load-bearing; 2=frequently moves, without load-bearing; The 3=load-bearing, the 1-2 step; The defective walking of 4=; The flawless walking of 5=).Animal is tested (they can no longer can be held and slip down from this plane in this angle) on clinoplain by every day, and checks hind leg grip (grip strength).Animal latter 14 days of operation by euthanasia and remove spinal column and carry out histological examination.
Experimental result provides in table 1 and 2, and " 0 " day is the operation same day.Several animals present minimum damage/defect and during weight falls, enough damages can not be arranged.( control animal 1,2,11 and treatment group animal 3,9,10.Referring to table 1 and 2).2 animals present serious/damage and not recovery fully.(control animal 5 and treatment group animal 2.Referring to table 1 and 2).Be sure of these remaining whole 7 control animals and 7 treatment group animals there is enough damages but be serious/damage fully.
For the purpose of analyzing, think that animal " recovery " is that it reaches at least 4/4 and scores that day.In 7 control animals, in the time of postoperative 8 days in one's hands, 3 animals do not return at least 4/4 score (right lower limb/left lower limb-defective walking (walking with deficit)).( animal 3,6,7, table 1).In remaining 4 control animals ( animal 4,8,9,10), 3 animals reached 4/4 at the 4th, 6 and 13 days scores, and 1 animal has reached 4/5 at the 7th day and scores.Therefore, 4 control animals are at average 7.5+/reached at least 4/4 in-3.35 days to score.For the treatment group animal, whole 7 animals ( animal 1,4,5,6,7,8,11) are at average 5.14+/reached at least 4/4 in-1.24 days to score.Therefore, it is evident that the spinal column to damage applies the speed (p=0.059) that 25mm Hg vacuum can increase functional rehabilitation.
Figure BPA00001159958200141
table 1. matched group
Figure BPA00001159958200142
Figure BPA00001159958200151
table 2. vacuum-therapy group
Experiment 3
Formulate the another kind of still scheme of the more serious damage that will cause irrecoverable (permanent) functional defect that wherein produces.Dampen the technology of the employing NYU contusion of spinal cord system of example based on W.M.Keck neuroscience joint study center (Center for Collaborative Neuroscience)-spinal cord injury research project (The Spinal Cord Injury Project) exploitation.These systems (being called at present " MASCIS ") are set up and can pass through the BiologyDepartment at Rutgers University (W.M.Keck neuroscience joint study center (Center for Collaborative Neuroscience) by conventional, Piscataway (Piscataway), New Jersey (New Jersey)) buy.
In above-mentioned experiment, animal is fixed the operation according to body weight, but animal determines according to the age to be performed the operation in this experiment.Long Evans hooded rat was performed the operation so that damage the seriousness standardization when 77 day age.Before operation between 1 and 6 day, some animals are by calm and be transported to the toy MRI imaging mechanism (the SmallAnimal MRI Imaging Facility of Wake Forest University School ofMedicine) of Wake Forest medical college, and adopt Bruker Biospin Horizontal Bore 7Tesla toy scanning device (Etta woods root (Ettlingen), Germany (Germany)) at T9-T10 horizontal sweep spinal cord.Then make the animal be scanned recover in anesthesia in the cage of heating.At the anesthetized animal on the same day of operation, and back part of animal is scraped hair and is adopted depilatory cream.Adopt aseptic technique, in the T9-T10 level, implement laminectomy.Adopt NYU contusion of spinal cord system impacting body (impactor) and use the 10 gram clubs that highly fall from 25mm to clash into spinal cord at T9-T10.The animal of matched group has the otch of the sealing sewed up, and animal is recovered in the cage of heating.For the treatment group animal, polyvinyl alcohol vacuum pack system (VersaFoam, Kinetic Concepts, Inc., San Antonio, TX) is placed on spinal cord, myometrial suture sealing, and apply 25mm Hg vacuum lower than atmospheric pressure 25mm Hg 8 hours.After this time, the treatment group animal, by again calm, is opened otch, removes vacuum pack system and again sews up sealing cut.If the animals received Postoperative MRI, animal is scanned 8 hours after shock.
Functional rehabilitation is marked with BBB, from 22 comments minute of W.M.Keck neuroscience joint study center (Center for Collaborative Neuroscience), is estimated.(table 3).Monitored 21 days of animal, then through being exposed to the CO of lethal dose<sub TranNum="165">2</sub>make euthanasia.Bladder is pushed by every day and the sign of the monitored autophagy metabolism of animal, decubital ulcer, skin lesion etc.Remove and anyly present the animal of autophagy metabolism sign and make euthanasia in research.Decubital ulcer and skin lesion are when appropriate and seek advice from ARP veterinary work personnel and treated.Although this nursing is arranged, in the process of this experiment, some animal deads, and other animal is because other problem is left out.<tables TranNum="166" num="0001"> <table TranNum="167"> <tgroup TranNum="168" cols="1"> <colspec TranNum = "169" colname = "c001" colwidth = "100 % "/> <tbody TranNum="170"> <row TranNum="171"> <entry TranNum="172" morerows="1">, value ,,,, ,,,, ,,,, , condition, , 0, , , there is no observable hind limb movement , , 1,, , slight movement of one or two joints , usually the hip & / or knee, , 2, , , a stretching of a joint or joints stretching exercises with a slight movement of the other joints , 3, , , stretching two joints ,, 4,,, HL slight movement of all three joints , , 5, , , slight movement of two joints and a third joints stretching exercises , , 6, , , stretching two joints and slight movement of the third joint , 7 , all three joints of stretching exercises HL , , 8, , , no weight support paw foot wing song (Sweeping) or no weight support paw foot flat (Plantar,,,,,, placement),, 9,,, only in the standing posture ( that is, when at rest ) has to support the weight of the flat or occasionally , when </ entry> </ row> </ tbody> </ tgroup> </ table> </ tables> <tables TranNum="173" num="0002"> <table TranNum="174"> < tgroup TranNum = "175" cols = "1"> <colspec TranNum="176" colname="c001" colwidth="100%"/> <tbody TranNum="177"> <row TranNum="178"> <entry TranNum = "179" morerows = "1">,,,,, often or consistently support the weight of the back foot stride and non- stride , 10 , and occasionally support the weight of the foot ; non forelimb (FL) - HL coordination , 11, often to support the weight of consistent plantar stepping and non- FL-HL coordination , 12, often to support the weight of consistent plantar stepping and occasional FL-HL coordination , 13 , often to support consistent plantar stepping weight and often the FL-HL coordination , 14, when it is initially in contact with the surface , and just before the end of the standing posture of the foot from the ground or from time to time ,,,, , at the end when stepping , consistent weight supported plantar stepping , consistent FL-HL coordination and , ,,,, during the movement of the main paw position (pawposition) for the rotation ( inward or outward ) ; always If a ,,,, , the FL-HL coordination ; and occasional dorsal stepping , 15 , consistent plantar stepping and consistent FL-HL coordination ; and no forward movement during limb ,,,, , toe clearance (Toe, clearance) or occasional toe clearance ; major paw position and initial contact , ,,,, body parallel , 16, during a foot stepping gait and always consistent as one of the FL-HL coordination ; and body forward ,,,, , frequent toe clearance during exercise ; major paw position parallel to and at the time from initial contact , ,,,, earth rotation , and 17 , in consistently stepped foot during gait and consistent FL-HL coordination ; and body forward ,,,, , frequent toe clearance during exercise ; major paw position at initial contact and when the flat ground , ,,,, line , and 18 during the gait consistent plantar stepping and consistent FL-HL coordination ; and body forward ,,,, , consistent toe clearance occurs during exercise ; main the position of the feet flat during initial contact ,,,, , and from the ground when the line rotation , 19, during gait consistent plantar stepping and consistent FL-HL coordination ; and body forward , ,,,, consistently occurs during movement toe clearance ; major paw position at initial contact and leave, ,,,, while in parallel ; and tail down in some or all of the time , and 20 , consistent consistent plantar stepping and coordinated gait ; consistent toe clearance ; Lord, ,,,, paw position is parallel to the ground when the initial contact and ; and trunk instability ; tail always ,,, , , like a ground up , 21, consistent plantar stepping and consistent coordination of gait ; consistent toe clearance ; Lord, ,,,, paw position to standing posture for the entire period in parallel ; trunk stability consistent ; tail, ,,,, Department consistently upward </ entry> </ row> </ tbody> </ tgroup> </ table> </ tables> table 3.BBB movement rating scale
For these researchs of permanent damage, 36 rats with complete dura mater complete research analyzed.The animal of 11 (11) vacuum-therapy that begin one's study, due to urinary tract infection and renal failure, 1 animal was removed with 1 animal and removes 8 weeks the time in the time of 5 weeks.Therefore, the animal of 9 vacuum-therapy completes the research of 12 weeks.27 control animals start and complete research.The animal of vacuum-therapy presents larger functional rehabilitation rate (p<0.072) 3 weeks the time after damage: BBB scoring=12.818+/-1.401 (n=11) vacuum-therapy group is to 11.704+/-2.391 (n=27) matched group.The animal of vacuum-therapy presents significantly larger functional rehabilitation rate (p<0.001) 4 weeks the time after damage: BBB scoring=13.625+/-1.303 (n=11) vacuum-therapy group is to 11.500+/-0.707 matched group (n=27).Fig. 6 and 7.The recovery rate of vacuum-therapy animal is stable level, and the recovery level of control animals moves closer to the level of vacuum-therapy animal.Fig. 6 and 7.(note, studied 3 weeks of some animals (usually early stage in research), and the observed functional rehabilitation of some animals 12 weeks).
Except BBB estimates, adopt this is tested to method listed above, 2 sectional areas with the analyzed damage of animal MRI scanning front and rear spinal cord of complete dura mater change (for example, with mm 2mean) (scanning after the animal of vacuum-therapy is implemented to damage after treatment).In carrying out 4 animals of this analysis, only have the animal of 1 vacuum-therapy do not there is any technology or clash into error and can be used.In control animal, 1 has less height error, and its pin (release pin) of deviating from the contusion of spinal cord system closes when leave behind in foster place and occurs from it; All other control animals have significant shock error, and it hinders the analysis of spinal cord sectional area.The height that Machine Records falls the rat weight of vacuum-therapy is 24.8mm, and is 25.782mm for the height of control rats.
Forward Fig. 8 to, when scanning is carried out along spinal column (to afterbody), control animals shows that sectional area increases a little.To clashing into front scanning and clashing into rear scanning, both are apparent for this.More than damage, with the following position of damage, sectional area scans and clashes between rear scanning not remarkable different before shock.Before the above shock of damage, meansigma methods is 5.49mm 2+/-0.2 (n=5) is to clashing into rear meansigma methods 5.32mm 2+/-0.23 (n=4): p<0.211) (before the following shock of damage, meansigma methods is 6.81mm 2+/-0.25 (n=3) is to clashing into rear meansigma methods 6.46mm 2+/-0.78 (n=4): p<0.464).Yet, in impact site, significantly be greater than (p<0.001) shock starting section for sectional area after the control animals shock long-pending: clash into front area average 5.63mm 2+/-0.24 (n=5 scanning) is to area 6.43mm after average shock 2+/-0.32 (n=4 scanning).This most likely causes spinal cord swelling due to the restriction because of dura mater, because the bone that will become spinal cord diameter limiting factor is removed.
Do not resemble control animals, the animal of vacuum-therapy does not show that after vacuum-therapy the average diameter of damage location spinal cord increases, Fig. 9.Before the average shock of level of damage, area is 7.28mm 2+/-0.73 (n=4 scanning) is to area 7.03mm after average shock 2+/-0.99 (n=4 scanning) (p<0.73).The similarity of spinal cord size before damage location clashes into and after treatment is most likely owing to removing fluid in dura mater, so spinal cord keeps initial diameter.
Before the above area of damage clashes into, with scanning after treatment, be similar (there is no significant difference).Before shock, the above area of damage is that 7.79+/-0.64 (n=3 scanning) is to treating rear area 8.33+/-1.11 (n=5 scanning) (p<0.48).Below animal injury for vacuum-therapy, scan, after treatment, the sectional area of spinal cord significantly is greater than the sectional area before clashing into: clash into front area 7.61+/-0.43 (n=4 scanning) to treating rear area 10.76+/-0.35 (n=4 scanning), p<0.001.To the possible explanation that damages following spinal cord sectional area and increase, may be to be attributable to venous congestion.Perhaps, the vacuum applied may, automatically from the cerebrospinal fluid of spinal cord absorption on every side, make spinal cord expand to fill the canalis spinalis area in vertebral body.This expansion will play a part to make the dura mater internal pressure to reduce to minimum and contribute to the Cell protection vigor.
Those skilled in the art will be expressly understood these and other advantage of the present invention in above description.Therefore, those skilled in the art will appreciate that and can make and change or improve and do not deviate from extensive invention theory of the present invention embodiment described above.Therefore should be appreciated that and the invention is not restricted to specific embodiments described here, and be intended to comprise all changes and improvement, in the scope and spirit of the present invention that these changes and improvements are set forth in the claims.

Claims (17)

1. a device that is used for the treatment of the myeloid tissue of damage, it comprises:
But multiporous biological bond material, but this material has the pore structure that is shaped to allow gas communication between one or more holes of multiporous biological bond material and the myeloid tissue for the treatment of, but but the selected surface of multiporous biological bond material that the multiporous biological bond material is at least placed in the myeloid tissue of contiguous damage has enough little hole to prevent from being organized in wherein, grows; With
For generation of the vacuum source of negative pressure, but its in the mode with multiporous biological bond material gas communication to myeloid tissue's distribution negative pressure of being treated.
2. according to the device of claim 1, but wherein the multiporous biological bond material comprises out the chamber collagen protein.
3. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises polyglycols citron acid esters.
4. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises polyglycols citron acid esters and collagen protein.
5. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises elastin laminin, hyaluronic acid, alginate or its combination.
6. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises the electrospinning material.
7. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises cast-molding material.
8. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises printing material.
9. according to the device of claim 1 or 2 claim, but but the selected surface of multiporous biological bond material that wherein the multiporous biological bond material is at least placed in the myeloid tissue to contiguous damage has the pore size that is less than fibroblast and cord cell size.
10. according to the device of claim 1 or 2, but but wherein the multiporous biological bond material has the pore size that is greater than fibroblast and cord cell in the inside of biology bond material.
11. according to the device of claim 1 or 2, but but the position the selected surface of multiporous biological bond material that wherein the multiporous biological bond material is placed in the myeloid tissue except contiguous damage has the pore size that is greater than fibroblast and cord cell.
12. according to the device of claim 1 or 2 claim, but the protein motion that wherein pore size of multiporous biological bond material passes through even as big as allowing the large I of albumin.
13. according to the device of claim 1 or 2, but wherein the multiporous biological bond material comprises at least one sealed surface to prevent that negative pressure from therefrom transmitting.
14. according to the device of claim 1 or 2, but but the pore size that forms granulation tissue is impelled on the surface the surface of the selection that wherein the multiporous biological bond material comprises the multiporous biological bond material of placing even as big as the myeloid tissue except contiguous damage.
15., according to the device of claim 1 or 2, wherein vacuum source comprises vacuum pump.
16., according to the device of claim 1 or 2, its protective layer that comprises the myeloid tissue that is shaped to the covering damage is to keep negative pressure under the protective layer at the Spinal Cord tissue.
17., according to the device of claim 16, wherein protective layer comprises self attachment flaps.
CN200880121075.8A 2007-10-10 2008-10-09 Devices and methods for treating spinal cord tissue Expired - Fee Related CN101896140B (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US97888407P 2007-10-10 2007-10-10
US60/978,884 2007-10-10
US60/978884 2007-10-10
US8199708P 2008-07-18 2008-07-18
US61/081,997 2008-07-18
US61/081997 2008-07-18
US8855808P 2008-08-13 2008-08-13
US61/088558 2008-08-13
US61/088,558 2008-08-13
PCT/US2008/079364 WO2009049058A1 (en) 2007-10-10 2008-10-09 Devices and methods for treating spinal cord tissue

Publications (2)

Publication Number Publication Date
CN101896140A CN101896140A (en) 2010-11-24
CN101896140B true CN101896140B (en) 2014-01-08

Family

ID=40549559

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880121075.8A Expired - Fee Related CN101896140B (en) 2007-10-10 2008-10-09 Devices and methods for treating spinal cord tissue

Country Status (15)

Country Link
US (4) US8834520B2 (en)
EP (1) EP2205189B1 (en)
JP (1) JP5462175B2 (en)
KR (1) KR101600041B1 (en)
CN (1) CN101896140B (en)
AU (1) AU2008310819B2 (en)
BR (1) BRPI0817544A2 (en)
CA (1) CA2702239C (en)
DK (1) DK2205189T3 (en)
ES (1) ES2661762T3 (en)
HK (1) HK1150958A1 (en)
IL (1) IL204825A (en)
RU (1) RU2489993C2 (en)
WO (1) WO2009049058A1 (en)
ZA (1) ZA201002498B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377016B2 (en) 2007-01-10 2013-02-19 Wake Forest University Health Sciences Apparatus and method for wound treatment employing periodic sub-atmospheric pressure
BRPI0817544A2 (en) 2007-10-10 2017-05-02 Univ Wake Forest Health Sciences apparatus for treating damaged spinal cord tissue
WO2009089435A1 (en) * 2008-01-09 2009-07-16 Wake Forest University Health Sciences Device and method for treating central nervous system pathology
RU2544093C2 (en) 2008-07-18 2015-03-10 Уэйк Форест Юниверсити Хелс Сайенсиз Device and method for cardiac tissue modulation by local application of pressure below atmospheric for minimising cell death and injury
US8608776B2 (en) * 2008-10-29 2013-12-17 KCI Licencsing, Inc. Reduced-pressure, abdominal treatment systems and methods
EP2838607A4 (en) 2012-04-12 2015-12-30 Univ Wake Forest Health Sciences Design of a conduit for peripheral nerve replacement
US9320840B2 (en) 2012-10-05 2016-04-26 Luis F. Angel Catheter vacuum dressing apparatus and methods of use
CA2889559A1 (en) 2012-10-26 2014-05-01 Wake Forest University Health Sciences Novel nanofiber-based graft for heart valve replacement and methods of using the same
WO2014110214A1 (en) * 2013-01-10 2014-07-17 The Cleveland Clinic Foundation Deployable joint infection treatment system
WO2014150288A2 (en) 2013-03-15 2014-09-25 Insera Therapeutics, Inc. Vascular treatment devices and methods
CN108697423A (en) 2016-02-16 2018-10-23 伊瑟拉医疗公司 The part flow arrangement of suction unit and anchoring
USD847864S1 (en) 2018-01-22 2019-05-07 Insera Therapeutics, Inc. Pump
WO2019173249A1 (en) * 2018-03-05 2019-09-12 William Loudon Methods, materials, devices and systems for treating injuries to the central nervous system
DE102018113580A1 (en) 2018-06-07 2019-12-12 Christoph Karl METHOD AND DEVICE FOR PRODUCING AN IMPLANT

Family Cites Families (507)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB114754A (en) 1918-04-18
DE561757C (en) 1932-10-18 Georg Heuchemer Bell-shaped vaginal pessary
DE372727C (en) 1923-03-31 Ernst Moyat Device for pneumatic suction and pressure massage
GB190203090A (en) 1902-02-07 1902-06-25 William Hugh Alexander Improvements in Shields for Protecting Corns, Bunions, or Vaccination Spots.
US765746A (en) 1904-02-06 1904-07-26 A D Gustin Massage apparatus.
US774529A (en) 1904-08-29 1904-11-08 Charles C F Nieschang Electrothermic and vacuum appliance.
US843674A (en) 1906-06-20 1907-02-12 Edgar M Funk Massaging apparatus.
US1000001A (en) 1908-11-09 1911-08-08 Robert A C Holz Vacuum apparatus for hyperemic treatments.
US1007631A (en) 1909-02-16 1911-10-31 John Calvin Bascue Stalk-cutter.
FR500253A (en) 1919-05-30 1920-03-06 Maurice Leger Suction cup device
US1385346A (en) 1919-06-27 1921-07-19 Taylor Walter Herbert Surgical wound-dam
US1355846A (en) 1920-02-06 1920-10-19 David A Rannells Medical appliance
US1355679A (en) 1920-04-28 1920-10-12 Mcconnell Thomas Vacuum apparatus
SE84485C1 (en) 1931-04-08 1935-10-01
US1936129A (en) 1931-12-01 1933-11-21 Andrew J Fisk Method of treating the skin and device therefor
US2025492A (en) 1934-11-09 1935-12-24 Aird Andrew Wound drainage device
US2232254A (en) 1936-05-26 1941-02-18 Samuel Schadel Massage device
US2122121A (en) 1937-02-02 1938-06-28 Tillotson Joseph Elmer Surgical aspirated drainage cup
US2221758A (en) 1937-05-12 1940-11-19 Elmquist Francis Surgical dressing
US2195771A (en) 1937-11-09 1940-04-02 Estler Louis Edmond Surgical suction drainage cup
US2338339A (en) 1940-11-08 1944-01-04 Mere Massaging vibrator
US2280915A (en) 1941-04-03 1942-04-28 John H Johnson Device for irrigating and treating wounds
US2443481A (en) 1942-10-19 1948-06-15 Sene Leon Paul Device for the treatment of wounds and the like lesions
DK64055C (en) 1943-02-22 1945-10-29 Joergen Adolph Smith Bell for the Treatment of Muscles and Other Deeper Tissues in the Human or Animal Body.
DE847475C (en) 1944-08-22 1952-08-25 Heinrich C Ulrich Device for draining wounds
US2573791A (en) 1947-04-19 1951-11-06 John N M Howells Heat applying bandage
GB641061A (en) 1947-09-06 1950-08-02 James Donald Maclaurin Improvements in method of treating wounds
US2577945A (en) 1947-12-06 1951-12-11 Atherton Harold Starr Plaster or bandage for skin application
US2547758A (en) 1949-01-05 1951-04-03 Wilmer B Keeling Instrument for treating the male urethra
US2632443A (en) 1949-04-18 1953-03-24 Eleanor P Lesher Surgical dressing
CH296748A (en) 1951-04-12 1954-02-28 Ciba Geigy Process for the production of a body with a rotationally symmetrical cavity from a synthetic resin mass which can be hardened by means of heat and hollow bodies obtained by the process.
US2682873A (en) 1952-07-30 1954-07-06 Johnson & Johnson General purpose protective dressing
NL189176B (en) 1956-07-13 1900-01-01 Hisamitsu Pharmaceutical Co PLASTER BASED ON A SYNTHETIC RUBBER.
US2969057A (en) 1957-11-04 1961-01-24 Brady Co W H Nematodic swab
US3026874A (en) 1959-11-06 1962-03-27 Robert C Stevens Wound shield
US3042041A (en) 1960-03-09 1962-07-03 Mario E Jascalevich Device for draining wounds
US3115138A (en) 1960-07-14 1963-12-24 Mcelvenny Evacuator
FR1303238A (en) 1961-09-07 1962-09-07 Pad
US3315665A (en) 1963-10-11 1967-04-25 Norman A Macleod Method and apparatus for therapy of skin tissue
US3324855A (en) 1965-01-12 1967-06-13 Henry J Heimlich Surgical sponge stick
US3382867A (en) 1965-03-22 1968-05-14 Ruby L. Reaves Body portion developing device with combined vacuum and vibrating means
US3367332A (en) 1965-08-27 1968-02-06 Gen Electric Product and process for establishing a sterile area of skin
US3429313A (en) 1966-02-01 1969-02-25 Ram Domestic Products Co Medical drainage pump
US3520300A (en) 1967-03-15 1970-07-14 Amp Inc Surgical sponge and suction device
US3528416A (en) 1967-11-06 1970-09-15 Lawrence J Chamberlain Protective bandage
US3486504A (en) 1967-11-20 1969-12-30 Lawthan M Austin Jr Device for applying dressing,medication and suction
US3572340A (en) 1968-01-11 1971-03-23 Kendall & Co Suction drainage device
GB1273342A (en) 1968-01-31 1972-05-10 Nat Res Dev Improvements relating to fluid mattresses
NO134790C (en) 1968-07-09 1984-03-22 Smith & Nephew Kleber ,; PRESSURE SENSITIVE, WATERPUME-PERMEABLE PRODUCT FOR SKIN USE BY HUMANS.
US3568675A (en) 1968-08-30 1971-03-09 Clyde B Harvey Fistula and penetrating wound dressing
DE1963258C3 (en) 1969-12-17 1974-09-05 Atmos Fritzsching & Co, Gmbh, 7825 Lenzkirch Drainage device
US3610238A (en) 1970-04-28 1971-10-05 Us Health Education & Welfare Wound infection prevention device
US3682180A (en) 1970-06-08 1972-08-08 Coilform Co Inc Drain clip for surgical drain
BE789293Q (en) 1970-12-07 1973-01-15 Parke Davis & Co MEDICO-SURGICAL DRESSING FOR BURNS AND SIMILAR LESIONS
US3713622A (en) 1971-02-26 1973-01-30 Amp Inc Closure device for flexible tubing
US3753439A (en) 1971-08-24 1973-08-21 Elias & Brugarolas General purpose surgical drain
US3782377A (en) 1971-09-07 1974-01-01 Illinois Tool Works Sterile plastic shield
BE789739A (en) 1971-10-05 1973-04-05 Lock Peter M SURGICAL DRESSING
US3938540A (en) 1971-10-07 1976-02-17 Medical Development Corporation Vacuum-operated fluid bottle for tandem systems
US3782387A (en) 1972-02-29 1974-01-01 R Falabella Apparatus and methods for obtaining and making skin grafts
US3814095A (en) 1972-03-24 1974-06-04 H Lubens Occlusively applied anesthetic patch
US3812972A (en) 1972-05-02 1974-05-28 J Rosenblum Liquid filter and method for fabricating same
US3874387A (en) 1972-07-05 1975-04-01 Pasquale P Barbieri Valved hemostatic pressure cap
JPS5238680B2 (en) 1972-12-27 1977-09-30
US3826254A (en) 1973-02-26 1974-07-30 Verco Ind Needle or catheter retaining appliance
US3954105A (en) 1973-10-01 1976-05-04 Hollister Incorporated Drainage system for incisions or wounds in the body of an animal
CA1031647A (en) 1973-10-01 1978-05-23 Hollister Incorporated Drainage system for incisions or wounds in the body of an animal
US3992725A (en) 1973-11-16 1976-11-23 Homsy Charles A Implantable material and appliances and method of stabilizing body implants
US3908664A (en) 1974-03-01 1975-09-30 Herbert S Loseff Wound suction tube and retrograde flushing
US3993080A (en) 1974-03-01 1976-11-23 Loseff Herbert S Suction tube and retrograde flushing for wounds, body cavities and the like
US3903882A (en) 1974-04-19 1975-09-09 American Cyanamid Co Composite dressing
US3935863A (en) 1974-07-19 1976-02-03 Kliger Herbert L Surgical sponge
US3998227A (en) 1974-09-13 1976-12-21 Medical Development Corporation Regulator structure and system
US3978855A (en) 1975-01-17 1976-09-07 Ionics Lyo Products Company Polyurethane foam surgical dressing
USRE29319E (en) 1975-04-07 1977-07-26 Hollister Incorporated Drainage system for incisions or wounds in the body of an animal
US4191204A (en) 1975-04-14 1980-03-04 International Paper Company Pressure responsive fluid collection system
US4058123A (en) 1975-10-01 1977-11-15 International Paper Company Combined irrigator and evacuator for closed wounds
SU587941A1 (en) 1976-06-01 1978-01-15 Предприятие П/Я А-3959 Device for cleansing infected wounds and cavities
US4187852A (en) 1976-07-09 1980-02-12 The University Of Alabama Synthetic elastomeric insoluble cross-linked polypentapeptide
US4080970A (en) 1976-11-17 1978-03-28 Miller Thomas J Post-operative combination dressing and internal drain tube with external shield and tube connector
US4139004A (en) 1977-02-17 1979-02-13 Gonzalez Jr Harry Bandage apparatus for treating burns
GB1549756A (en) 1977-03-10 1979-08-08 Everett W Wound irrigating device
US4184510A (en) 1977-03-15 1980-01-22 Fibra-Sonics, Inc. Valued device for controlling vacuum in surgery
US4156066A (en) 1977-06-23 1979-05-22 Tyndale Plains - Hunter Ltd. Polyurethane polymers characterized by lactone groups and hydroxyl groups in the polymer backbone
US4149541A (en) 1977-10-06 1979-04-17 Moore-Perk Corporation Fluid circulating pad
CH623546A5 (en) 1977-11-09 1981-06-15 Schweiter Ag Maschf
US4245637A (en) 1978-07-10 1981-01-20 Nichols Robert L Shutoff valve sleeve
US4224945A (en) 1978-08-30 1980-09-30 Jonathan Cohen Inflatable expansible surgical pressure dressing
US4224941A (en) 1978-11-15 1980-09-30 Stivala Oscar G Hyperbaric treatment apparatus
SE414994B (en) 1978-11-28 1980-09-01 Landstingens Inkopscentral VENKATETERFORBAND
BR7908937A (en) 1978-12-06 1981-06-30 Svedman Paul DEVICE FOR TREATING FABRICS, FOR EXAMPLE, SKIN
US4250882A (en) 1979-01-26 1981-02-17 Medical Dynamics, Inc. Wound drainage device
US4221215A (en) 1979-04-19 1980-09-09 Isidore Mandelbaum Anchoring and occluding surgical dressing
US4261363A (en) 1979-11-09 1981-04-14 C. R. Bard, Inc. Retention clips for body fluid drains
EP0035583B1 (en) 1980-03-11 1985-08-14 Schmid, Eduard, Dr.Dr.med. Skin graft pressure bandage
US4399816A (en) 1980-03-17 1983-08-23 Spangler George M Wound protector with transparent cover
US5445604A (en) 1980-05-22 1995-08-29 Smith & Nephew Associated Companies, Ltd. Wound dressing with conformable elastomeric wound contact layer
US4297995A (en) 1980-06-03 1981-11-03 Key Pharmaceuticals, Inc. Bandage containing attachment post
IE51473B1 (en) 1980-08-13 1986-12-24 Smith & Nephew Ass Polymer blend films,their preparation and use
US4341209A (en) 1981-01-12 1982-07-27 The Kendall Company Adhesive bandage with foam backing
DE3102674A1 (en) 1981-01-28 1982-09-02 Walter Dr.-Ing. 5100 Aachen Jürgens Bandaging material
US4753231A (en) 1981-02-13 1988-06-28 Smith & Nephew Associated Companies P.L.C. Adhesive wound dressing
US4860737A (en) 1981-02-13 1989-08-29 Smith And Nephew Associated Companies P.L.C. Wound dressing, manufacture and use
NZ199684A (en) 1981-02-13 1985-03-20 Smith & Nephew Ass Wound dressing;wound facing layer a conformable elastomeric integral net
US4465485A (en) 1981-03-06 1984-08-14 Becton, Dickinson And Company Suction canister with unitary shut-off valve and filter features
US4392853A (en) 1981-03-16 1983-07-12 Rudolph Muto Sterile assembly for protecting and fastening an indwelling device
US4457755A (en) 1981-04-02 1984-07-03 Wilson John D Surgical `in-line` evacuator
US4373519A (en) 1981-06-26 1983-02-15 Minnesota Mining And Manufacturing Company Composite wound dressing
US4419097A (en) 1981-07-31 1983-12-06 Rexar Industries, Inc. Attachment for catheter tube
US4459139A (en) 1981-09-14 1984-07-10 Gelman Sciences Inc. Disposable filter device and liquid aspirating system incorporating same
SE429197B (en) 1981-10-14 1983-08-22 Frese Nielsen SAR TREATMENT DEVICE
DE3146266A1 (en) 1981-11-21 1983-06-01 B. Braun Melsungen Ag, 3508 Melsungen COMBINED DEVICE FOR A MEDICAL SUCTION DRAINAGE
US4499896A (en) 1982-03-30 1985-02-19 Minnesota Mining And Manufacturing Co. Reservoir wound dressing
US4475909A (en) 1982-05-06 1984-10-09 Eisenberg Melvin I Male urinary device and method for applying the device
US4465062A (en) 1982-05-14 1984-08-14 Gina Versaggi Noninvasive seal for a sucking chest wound
NL8202893A (en) 1982-07-16 1984-02-16 Rijksuniversiteit ORGANIC Tolerant, ANTHITHROMBOGENIC MATERIAL, SUITABLE FOR RECOVERY SURGERY.
US4569674A (en) 1982-08-03 1986-02-11 Stryker Corporation Continuous vacuum wound drainage system
IT211654Z2 (en) 1985-07-17 1989-04-07 Abbate Mariarosa VARIABLE DEPRESSION TREATMENT APPARATUS FOR LOCATION, AMPLITUDE AND FREQUENCY WITH ELECTRONIC COMMAND AND CONTROL.
NZ206837A (en) 1983-01-27 1986-08-08 Johnson & Johnson Prod Inc Thin film adhesive dressing:backing material in three sections
US4533352A (en) 1983-03-07 1985-08-06 Pmt Inc. Microsurgical flexible suction mat
SU1251912A1 (en) 1983-04-27 1986-08-23 Горьковский государственный медицинский институт им.С.М.Кирова Method of treatment of unformed fistula
DE3321151C2 (en) 1983-06-11 1986-09-18 Walter Küsnacht Beck Device for aspirating secretions
US4540412A (en) 1983-07-14 1985-09-10 The Kendall Company Device for moist heat therapy
US4778446A (en) 1983-07-14 1988-10-18 Squibb & Sons Inc Wound irrigation and/or drainage device
US4624656A (en) 1983-07-25 1986-11-25 Hospitak, Inc. Hyperbaric gas treatment device
US4553967A (en) 1983-10-14 1985-11-19 E. R. Squibb & Sons, Inc. Wound care and drainage system having hand access port
US4543100A (en) 1983-11-01 1985-09-24 Brodsky Stuart A Catheter and drain tube retainer
US4579555A (en) 1983-12-05 1986-04-01 Sil-Fab Corporation Surgical gravity drain having aligned longitudinally extending capillary drainage channels
US4573965A (en) 1984-02-13 1986-03-04 Superior Plastic Products Corp. Device for draining wounds
US4837285A (en) 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
SU1268175A1 (en) 1984-03-27 1986-11-07 Deneka Evgenij R Apparatus for vacuum-massage
GB2157958A (en) 1984-05-03 1985-11-06 Ernest Edward Austen Bedding Ball game net support
US4897081A (en) 1984-05-25 1990-01-30 Thermedics Inc. Percutaneous access device
GB8419745D0 (en) 1984-08-02 1984-09-05 Smith & Nephew Ass Wound dressing
US4872450A (en) 1984-08-17 1989-10-10 Austad Eric D Wound dressing and method of forming same
US4679590A (en) 1984-08-31 1987-07-14 Hergenroeder Patrick T Receptacle for collecting fluids
US4627427A (en) 1984-10-17 1986-12-09 Minnesota Mining And Manufacturing Company Universal medical cover sheet and process for draping
US4655754A (en) 1984-11-09 1987-04-07 Stryker Corporation Vacuum wound drainage system and lipids baffle therefor
DE3441893A1 (en) 1984-11-16 1986-05-28 Walter Küsnacht Beck METHOD AND DEVICE FOR SUCTIONING SECRETARY LIQUID FROM A Wound
US4605399A (en) 1984-12-04 1986-08-12 Complex, Inc. Transdermal infusion device
US4773409A (en) 1985-09-20 1988-09-27 E. R. Squibb & Sons, Inc. Wound dressing
US4664652A (en) 1985-02-07 1987-05-12 Snyder Laboratories, Inc. Wound evacuator
US4717382A (en) 1985-04-18 1988-01-05 Emergency Management Products, Inc. Noninvasive apparatus for treating a sucking chest wound
JPH0648860Y2 (en) 1985-05-29 1994-12-12 沖電気工業株式会社 Jig for semiconductor wafer
US4637819A (en) 1985-05-31 1987-01-20 The Procter & Gamble Company Macroscopically expanded three-dimensional polymeric web for transmitting both dynamically deposited and statically contacted fluids from one surface to the other
GB2176402B (en) 1985-06-20 1989-04-19 Craig Med Prod Ltd Wound management appliance for use on the human skin
WO1987000439A1 (en) 1985-07-16 1987-01-29 General Polymeric Corporation Fluid-flow controlling device and apparatus employing same
SU1416108A1 (en) 1985-07-24 1988-08-15 Харьковский Научно-Исследовательский Институт Ортопедии И Травматологии Им.Проф.М.И.Ситенко Method of curing open wounds
US4640688A (en) 1985-08-23 1987-02-03 Mentor Corporation Urine collection catheter
US4710165A (en) 1985-09-16 1987-12-01 Mcneil Charles B Wearable, variable rate suction/collection device
US4633863A (en) 1985-09-27 1987-01-06 Filips Chester P Arterial anchor bandage
DE3539533A1 (en) 1985-11-07 1987-05-14 Liedtke Pharmed Gmbh Plastic plaster
US4733659A (en) 1986-01-17 1988-03-29 Seton Company Foam bandage
WO1987004626A1 (en) 1986-01-31 1987-08-13 Osmond, Roger, L., W. Suction system for wound and gastro-intestinal drainage
US4838883A (en) 1986-03-07 1989-06-13 Nissho Corporation Urine-collecting device
US4875473A (en) 1986-04-03 1989-10-24 Bioderm, Inc. Multi-layer wound dressing having oxygen permeable and oxygen impermeable layers
US4667666A (en) 1986-04-18 1987-05-26 Alice Fryslie Protective bandaging device
CH670049A5 (en) 1986-04-24 1989-05-12 Vebo
US4641643A (en) 1986-04-28 1987-02-10 Greer Leland H Resealing skin bandage
JPS62281965A (en) 1986-05-29 1987-12-07 テルモ株式会社 Catheter and catheter fixing member
GB8620227D0 (en) 1986-08-20 1986-10-01 Smith & Nephew Ass Wound dressing
GB8621884D0 (en) 1986-09-11 1986-10-15 Bard Ltd Catheter applicator
GB2195255B (en) 1986-09-30 1991-05-01 Vacutec Uk Limited Apparatus for vacuum treatment of an epidermal surface
US4743232A (en) 1986-10-06 1988-05-10 The Clinipad Corporation Package assembly for plastic film bandage
DE3634569A1 (en) 1986-10-10 1988-04-21 Sachse Hans E CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS
DE3751254D1 (en) 1986-10-31 1995-05-24 Nippon Zeon Co Wound dressing.
US5736372A (en) 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
JPS63135179A (en) 1986-11-26 1988-06-07 立花 俊郎 Subcataneous drug administration set
US4759354A (en) 1986-11-26 1988-07-26 The Kendall Company Wound dressing
US4820265A (en) 1986-12-16 1989-04-11 Minnesota Mining And Manufacturing Company Tubing set
DE3644588C1 (en) 1986-12-27 1988-03-10 Ethicon Gmbh Implant and process for its manufacture
US4764167A (en) 1987-01-14 1988-08-16 Tu Ho C Safety newborn mucous suction device
DE3880129D1 (en) 1987-01-20 1993-05-13 Medinorm Ag DEVICE FOR SUCTIONING WINDING LIQUIDS.
WO1988006023A1 (en) 1987-02-20 1988-08-25 Klaus Draenert Suction drainage-bone screw
GB8706116D0 (en) 1987-03-14 1987-04-15 Smith & Nephew Ass Adhesive dressings
US4778456A (en) 1987-04-03 1988-10-18 Oddvin Lokken Method of sterilizing an operating field and sterilized cassette therefor
US4747166A (en) 1987-05-15 1988-05-31 Kuntz David H Fluid aspiration system for the management of urinary incontinence
US5035884A (en) 1987-06-02 1991-07-30 Warner-Lambert Company Methylene pyrrolidone copolymers for contact lens and pharmaceutical preparations
US4851545A (en) 1987-06-02 1989-07-25 Warner-Lambert Company N-substituted-3-alkylene-2-pyrrolidone compounds
US4931519A (en) 1987-06-02 1990-06-05 Warner-Lambert Company Copolymers from n-alkyl-3-alkenylene-2-pyrrolidone
ATE59303T1 (en) 1987-06-22 1991-01-15 Takeda Chemical Industries Ltd SUCTION DEVICE FOR MEDICAL OPERATION.
JPH0788433B2 (en) 1987-06-26 1995-09-27 ニッピコラ−ゲン工業株式会社 Collagen sponge
US4863449A (en) 1987-07-06 1989-09-05 Hollister Incorporated Adhesive-lined elastic condom cathether
US5002529A (en) 1987-07-10 1991-03-26 Solco Basle, Inc. Postoperative wound drainage
FI77569C (en) 1987-07-13 1989-04-10 Huhtamaeki Oy ANORDINATION FOR THE PURPOSE OF THE OPERATIONS AND THE OPERATIONS OF ELLER EN VAEVNAD.
FR2618337B1 (en) 1987-07-22 1989-12-15 Dow Corning Sa SURGICAL DRESSING AND PROCESS FOR MAKING SAME
US4822278A (en) 1987-10-16 1989-04-18 The Wilkinson Dental Manufacturing Company, Inc. Dental veneer instrument
IT8748594A0 (en) 1987-11-09 1987-11-09 Checconi Pietro E Matteucci Do DRESSING PATCH WITH BUILT-IN SPACER
US5176663A (en) 1987-12-02 1993-01-05 Pal Svedman Dressing having pad with compressibility limiting elements
US4834110A (en) 1988-02-01 1989-05-30 Richard Patricia A Suction clamped treatment cup saliva sampler
US4906240A (en) 1988-02-01 1990-03-06 Matrix Medica, Inc. Adhesive-faced porous absorbent sheet and method of making same
US4921492A (en) 1988-05-31 1990-05-01 Laser Technologies Group, Inc. End effector for surgical plume evacuator
US4925447A (en) 1988-06-22 1990-05-15 Rosenblatt/Ima Invention Enterprises Aspirator without partition wall for collection of bodily fluids including improved safety and efficiency elements
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5024841A (en) 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US4917112A (en) 1988-08-22 1990-04-17 Kalt Medical Corp. Universal bandage with transparent dressing
US5003971A (en) 1988-09-02 1991-04-02 Buckley John T Expansion system for a medical and surgical dressing
US5215539A (en) 1988-10-12 1993-06-01 Schoolman Scientific Corporation Vacuum strip apparatus for surgery
GB8906100D0 (en) 1989-03-16 1989-04-26 Smith & Nephew Laminates
US5261893A (en) 1989-04-03 1993-11-16 Zamierowski David S Fastening system and method
US5100396A (en) 1989-04-03 1992-03-31 Zamierowski David S Fluidic connection system and method
US5527293A (en) 1989-04-03 1996-06-18 Kinetic Concepts, Inc. Fastening system and method
US4969880A (en) 1989-04-03 1990-11-13 Zamierowski David S Wound dressing and treatment method
US5086764A (en) 1989-04-13 1992-02-11 Thomas Gilman Absorbent dressing
US5106362A (en) 1989-04-13 1992-04-21 The Kendall Company Vented absorbent dressing
SE462516B (en) 1989-07-11 1990-07-09 Paal Svedman WOOL TAPE FOR DEEP SAAR
JP2719671B2 (en) 1989-07-11 1998-02-25 日本ゼオン株式会社 Wound dressing
US5358494A (en) 1989-07-11 1994-10-25 Svedman Paul Irrigation dressing
US5042978A (en) 1989-08-08 1991-08-27 Eastman Kodak Company Container using a mass of porous material for liquid retention
JPH0336640U (en) 1989-08-23 1991-04-10
US5019086A (en) 1989-09-12 1991-05-28 Neward Theodore C Manipulable vacuum extractor for childbirth and method of using the same
US4988336A (en) 1989-09-22 1991-01-29 Allied Healthcare Products, Inc. Electronic suction regulator
US5106629A (en) 1989-10-20 1992-04-21 Ndm Acquisition Corp. Transparent hydrogel wound dressing
DE4111122A1 (en) 1989-10-27 1993-04-29 Wolfgang Dr Neher Equipment for cleansing and therapeutic treatment of wounds - has rubber sleeves or bell shaped covers to seal treatment area with pumped circulation and cleaning of fluid media in closed circuit
US4969881A (en) 1989-11-06 1990-11-13 Connecticut Artcraft Corp. Disposable hyperbaric oxygen dressing
US5071403A (en) 1989-11-14 1991-12-10 Isg/Ag Method and apparatus for protecting the pump of a breast pump from fouling by milk
US5014389A (en) 1989-11-15 1991-05-14 Concept Inc. Foot manipulated suction head and method for employing same
US5152757A (en) 1989-12-14 1992-10-06 Brigham And Women's Hospital System for diagnosis and treatment of wounds
US5002528A (en) 1989-12-15 1991-03-26 Aubrey Palestrant Percutaneous irrigation and drainage system
NL9000356A (en) 1990-02-14 1991-09-02 Cordis Europ DRAINAGE CATHETER.
US5228431A (en) 1990-04-26 1993-07-20 Giarretto Ralph R Drug-free method for treatment of the scalp for therapeutic purposes
SE470347B (en) 1990-05-10 1994-01-31 Pharmacia Lkb Biotech Microstructure for fluid flow systems and process for manufacturing such a system
US5060662A (en) 1990-07-06 1991-10-29 Farnswoth Iii Kenneth F Open air bandage
US5086763A (en) 1990-08-06 1992-02-11 Hathman Johnnie L Protective reclosable wound dressing
US5135518A (en) 1990-08-28 1992-08-04 Barbara Vera Heat-retentive wet compress
US5451215A (en) 1990-09-17 1995-09-19 Wolter; Dietmar Suction drain for the aspiration of discharges
EP0485657A1 (en) 1990-11-15 1992-05-20 Catalina Biomedical Corporation Modifiable, semi permeable wound dressing
DE4037931A1 (en) 1990-11-23 1992-05-27 Detlef Dr Ing Behrend Swab for resorbable protection of wound cavity - with soft foam body in soft foam casing with embedded resorbable hollow fibres connected to tube
AU1239692A (en) 1991-01-18 1992-08-27 Delamar Gibbons Body vacuum
US5697920A (en) 1991-01-18 1997-12-16 Gibbons; De Lamar Body vacuum
US5160322A (en) 1991-02-28 1992-11-03 Brunswick Biomedical Technologies, Inc. Occlusive chest sealing valve
US5419768A (en) 1991-03-07 1995-05-30 Aeros Instruments, Inc. Electrical medical vacuum regulator
US5199443A (en) 1991-03-26 1993-04-06 Empi, Inc. Incontinence electrode apparatus
US5149331A (en) 1991-05-03 1992-09-22 Ariel Ferdman Method and device for wound closure
US5230350A (en) 1991-05-29 1993-07-27 Tabex Industries, Inc. Moisture barrier for indwelling catheters and the like
GB9113448D0 (en) 1991-06-21 1991-08-07 Smith & Nephew Adhesive compositions and products
US5263922A (en) 1991-08-26 1993-11-23 Plasco, Inc. Valved bandage
US5224947A (en) 1991-10-21 1993-07-06 Cooper Richard N Soft, readily expandable vacuum bell assembly
US5645081A (en) 1991-11-14 1997-07-08 Wake Forest University Method of treating tissue damage and apparatus for same
US5636643A (en) 1991-11-14 1997-06-10 Wake Forest University Wound treatment employing reduced pressure
US7198046B1 (en) 1991-11-14 2007-04-03 Wake Forest University Health Sciences Wound treatment employing reduced pressure
US5170781A (en) 1991-11-15 1992-12-15 Loomis Dawn L Protective bandage having improved impact protection
CA2070590C (en) 1991-12-16 2002-10-01 Kimberly-Clark Worldwide, Inc. Surgical fluid evacuation system
WO1993013735A1 (en) 1992-01-17 1993-07-22 Dobloug, Anette A heat conserving bandage
US5431662A (en) 1992-02-12 1995-07-11 United States Surgical Corporation Manipulator apparatus
US5484399A (en) 1992-02-27 1996-01-16 Sloan-Kettering Institute For Cancer Research Process and device to reduce interstitial fluid pressure in tissue
US5167613A (en) 1992-03-23 1992-12-01 The Kendall Company Composite vented wound dressing
DK168420B1 (en) 1992-03-27 1994-03-28 Coloplast As A heat dressing
US5176667A (en) 1992-04-27 1993-01-05 Debring Donald L Liquid collection apparatus
EP0648264A4 (en) 1992-06-03 1997-10-01 Univ Case Western Reserve Bandage for continuous application of biologicals.
ES2125993T3 (en) 1992-06-19 1999-03-16 Scott D Augustine WOUND COATING.
US5947914A (en) 1995-02-21 1999-09-07 Augustine Medical, Inc. Wound covering
US5986163A (en) 1992-06-19 1999-11-16 Augustine Medical, Inc. Normothermic heater wound covering
US5964723A (en) 1992-06-19 1999-10-12 Augustine Medical, Inc. Normothermic tissue heating wound covering
US5954680A (en) 1992-06-19 1999-09-21 Augustine Medical, Inc. Near hyperthermic heater wound covering
DE4221006C2 (en) 1992-06-26 1994-06-30 S & G Implants Gmbh Implant to replace a back patella part
US5678564A (en) 1992-08-07 1997-10-21 Bristol Myers Squibb Liquid removal system
US5354268A (en) 1992-11-04 1994-10-11 Medical Instrument Development Laboratories, Inc. Methods and apparatus for control of vacuum and pressure for surgical procedures
DE4310968C2 (en) 1993-04-03 1995-08-10 Kubein Meesenburg Dietmar Artificial joint as an endoprosthesis for the human patella joint
US5645537A (en) * 1993-04-20 1997-07-08 Advanced Cytometrix, Inc. Aspiration needle and syringe for use therewith, apparatus incorporating the same and kit for use in fine needle aspiration cytology, and method
US5330452A (en) 1993-06-01 1994-07-19 Zook Gerald P Topical medicating device
US5478333A (en) 1994-03-04 1995-12-26 Asherman, Jr.; Richard E. Medical dressing for treating open chest injuries
US5344415A (en) 1993-06-15 1994-09-06 Deroyal Industries, Inc. Sterile system for dressing vascular access site
DE69432750T2 (en) 1993-07-08 2004-04-29 Aircast Inc. DEVICE FOR ENABLING A THERAPEUTIC INTERMITTENTAL COMPRESSION TO REDUCE THE RISK OF VENENTHROMBOSE
US5607590A (en) 1993-08-06 1997-03-04 Shimizu; Yasuhiko Material for medical use and process for preparing same
WO1995005864A1 (en) 1993-08-27 1995-03-02 Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services Convection-enhanced drug delivery
US5437651A (en) 1993-09-01 1995-08-01 Research Medical, Inc. Medical suction apparatus
US5490962A (en) 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US5599330A (en) 1993-11-23 1997-02-04 Rainin; Edgar A. Surgical wicking device
US5447492A (en) 1993-12-20 1995-09-05 New Dimensions In Medicine, Inc. External fixation dressing for accommodating a retaining pin
US5496262A (en) 1994-01-06 1996-03-05 Aircast, Inc. Therapeutic intermittent compression system with inflatable compartments of differing pressure from a single source
DE4403509A1 (en) 1994-02-04 1995-08-10 Draenert Klaus Material and process for its manufacture
US5549584A (en) 1994-02-14 1996-08-27 The Kendall Company Apparatus for removing fluid from a wound
US5456267A (en) 1994-03-18 1995-10-10 Stark; John G. Bone marrow harvesting systems and methods and bone biopsy systems and methods
US5626861A (en) 1994-04-01 1997-05-06 Massachusetts Institute Of Technology Polymeric-hydroxyapatite bone composite
US6786879B1 (en) 1994-04-05 2004-09-07 Kci Licensing, Inc. Gradient sequential compression system for preventing deep vein thrombosis
AU1999995A (en) 1994-04-08 1995-11-10 Atrix Laboratories, Inc. An adjunctive polymer system for use with medical device
IL109344A (en) 1994-04-19 1998-02-22 Mendes David Prosthetic patella implant of the knee joint
US6159246A (en) 1994-04-19 2000-12-12 Mendes; David Surgical method and tool for repairing a patella of the knee joint
GB9409281D0 (en) 1994-05-10 1994-06-29 Svedman Paul Transdermal device
US5556375A (en) 1994-06-16 1996-09-17 Hercules Incorporated Wound dressing having a fenestrated base layer
US5607388A (en) 1994-06-16 1997-03-04 Hercules Incorporated Multi-purpose wound dressing
ATE172377T1 (en) 1994-08-22 1998-11-15 Kinetic Concepts Inc WOUND DRAINAGE DEVICE
DE4433450A1 (en) 1994-09-20 1996-03-21 Wim Dr Med Fleischmann Device for sealing a wound area
DE4439240A1 (en) 1994-11-03 1996-05-09 Michael Krug Packing for elongated objects esp. folded blinds
US5876359A (en) 1994-11-14 1999-03-02 Bock; Malcolm G. Sequential compression device controller
US6110197A (en) 1994-11-21 2000-08-29 Augustine Medical, Inc. Flexible non-contact wound treatment device with a single joint
US6093160A (en) 1994-11-21 2000-07-25 Augustine Medical, Inc. Flexible non-contact wound treatment device
US5817145A (en) 1994-11-21 1998-10-06 Augustine Medical, Inc. Wound treatment device
US5542918A (en) 1995-01-06 1996-08-06 Zimmer, Inc. Vacuum driven fluid pump for an aspiration/irrigation instrument
DE29504378U1 (en) 1995-03-15 1995-09-14 Mtg Medizinisch Tech Geraeteba Electronically controlled low-vacuum pump for chest and wound drainage
US5578022A (en) 1995-04-12 1996-11-26 Scherson; Daniel A. Oxygen producing bandage and method
GB9508606D0 (en) 1995-04-27 1995-06-14 Svedman Paul Suction blister sampling
DE19517699C2 (en) 1995-05-13 1999-11-04 Wilhelm Fleischmann Device for vacuum sealing a wound
GB2301362B (en) 1995-05-30 1999-01-06 Johnson & Johnson Medical Absorbable implant materials having controlled porosity
JP2636799B2 (en) 1995-05-31 1997-07-30 日本電気株式会社 Leachate suction device
US5656027A (en) 1995-06-06 1997-08-12 Cobe Laboratories, Inc. Surgical fluid suction accumulator and volume measurement device
US5716360A (en) 1995-06-30 1998-02-10 U.S. Medical Products Patella recession instrument and method for anatomically-shaped patellar prostheses
US8282596B2 (en) 1999-12-10 2012-10-09 Medela Holding Ag Breastpump with letdown feature
FR2737968B1 (en) 1995-08-23 1997-12-05 Biomat IMPLANT FOR OSTEOSYNTHESIS OF SUPERIOR FEMALE EPIPHYSIS
NZ315995A (en) 1995-09-01 1999-09-29 Millenium Biologix Inc Artificial sintered composition comprising stabilised calcium phosphate phases capable of supporting bone cell activity
US5836311A (en) 1995-09-20 1998-11-17 Medtronic, Inc. Method and apparatus for temporarily immobilizing a local area of tissue
US5776193A (en) 1995-10-16 1998-07-07 Orquest, Inc. Bone grafting matrix
US6095148A (en) 1995-11-03 2000-08-01 Children's Medical Center Corporation Neuronal stimulation using electrically conducting polymers
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
GB9523253D0 (en) 1995-11-14 1996-01-17 Mediscus Prod Ltd Portable wound treatment apparatus
DE19546664C2 (en) 1995-12-14 1999-02-11 Laabs Walter Suction device for medical purposes
US5628735A (en) 1996-01-11 1997-05-13 Skow; Joseph I. Surgical device for wicking and removing fluid
US5951295A (en) 1996-02-08 1999-09-14 Materials Evolution And Development Usa, Inc. Ceramic fused fiber enhanced dental materials
US6087553A (en) 1996-02-26 2000-07-11 Implex Corporation Implantable metallic open-celled lattice/polyethylene composite material and devices
JP2964942B2 (en) 1996-02-28 1999-10-18 日本電気株式会社 Suction leachate collection device
US5827246A (en) 1996-02-28 1998-10-27 Tecnol Medical Products, Inc. Vacuum pad for collecting potentially hazardous fluids
US5655258A (en) 1996-03-12 1997-08-12 Heintz; J. Aaron Device for aspirating fluids from hospital operating room floor
US5868749A (en) 1996-04-05 1999-02-09 Reed; Thomas M. Fixation devices
US5662625A (en) 1996-05-06 1997-09-02 Gwr Medical, L.L.P. Pressure controllable hyperbaric device
US6143948A (en) 1996-05-10 2000-11-07 Isotis B.V. Device for incorporation and release of biologically active agents
SE9601853L (en) 1996-05-14 1997-06-09 Moelnlycke Ab Wound dressing and manufacturing process therefore
US6332871B1 (en) 1996-05-17 2001-12-25 Amira Medical Blood and interstitial fluid sampling device
US5662598A (en) 1996-06-27 1997-09-02 Tobin; Joshua M. Silicone occlusive dressing for penetrating thoracic trauma
US6673028B1 (en) 1996-09-26 2004-01-06 Wake Forest University Health Sciences Passive joint movement device and method for using the same
US5735833A (en) 1996-12-11 1998-04-07 Bristol-Myers Squibb Co. Lavage tip
US5810840A (en) 1997-01-14 1998-09-22 Lindsay; Richard G. Vacuum extractor
JP2985816B2 (en) 1997-02-04 1999-12-06 日本電気株式会社 Liquid sampling device
US5941859A (en) 1997-03-17 1999-08-24 Lerman; Benjamin S. Wound irrigation shield with fluid scavenging
US5935136A (en) 1997-05-09 1999-08-10 Pristech, Inc. Obstetrical vacuum extractor cup with soft molded lip
DE19722075C1 (en) 1997-05-27 1998-10-01 Wilhelm Dr Med Fleischmann Medication supply to open wounds
US7759538B2 (en) 1997-05-27 2010-07-20 Wilhelm Fleischmann Process and device for application of active substances to a wound surface
DE59809764D1 (en) 1997-05-27 2003-11-06 Wilhelm Fleischmann Device for applying active substances to a wound surface
US6484716B1 (en) 1997-07-22 2002-11-26 Kci Licensing, Inc. Hyperbaric oxygen patient treatment system with therapeutic surface
US6135116A (en) 1997-07-28 2000-10-24 Kci Licensing, Inc. Therapeutic method for treating ulcers
US7214202B1 (en) 1997-07-28 2007-05-08 Kci Licensing, Inc. Therapeutic apparatus for treating ulcers
US6080243A (en) 1998-06-18 2000-06-27 3M Innovative Properties Company Fluid guide device having an open structure surface for attachement to a fluid transport source
US6420622B1 (en) 1997-08-01 2002-07-16 3M Innovative Properties Company Medical article having fluid control film
US6290685B1 (en) 1998-06-18 2001-09-18 3M Innovative Properties Company Microchanneled active fluid transport devices
GB9719520D0 (en) 1997-09-12 1997-11-19 Kci Medical Ltd Surgical drape and suction heads for wound treatment
US7273054B2 (en) 1997-09-12 2007-09-25 Kci Licensing, Inc. Surgical drape and head for wound treatment
US5919476A (en) 1997-09-29 1999-07-06 Pmt Corporation Reinforced gel sheeting for scar treatment
WO1999018892A1 (en) 1997-10-09 1999-04-22 Cambridge Scientific, Inc. Biodegradable, biopolymeric bioelectret implant for tissue regeneration
US6106913A (en) 1997-10-10 2000-08-22 Quantum Group, Inc Fibrous structures containing nanofibrils and other textile fibers
US6053416A (en) 1997-10-29 2000-04-25 Kci Industries, Inc. Automatic hydronic zone valve and electric controls therefor
US5928174A (en) 1997-11-14 1999-07-27 Acrymed Wound dressing device
US6712851B1 (en) 1998-01-23 2004-03-30 Macropore Biosurgery, Inc. Resorbable, macro-porous non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US6071267A (en) 1998-02-06 2000-06-06 Kinetic Concepts, Inc. Medical patient fluid management interface system and method
AU3118499A (en) 1998-04-03 1999-10-25 Beth Israel Deaconess Medical Center Soft tissue reconstructor and method of use
US6071304A (en) 1998-04-06 2000-06-06 Augustine Medical, Inc. Wound treatment apparatus with a heater adhesively joined to a bandage
US6095992A (en) 1998-04-06 2000-08-01 Augustine Medical, Inc. Wound treatment apparatus for normothermic treatment of wounds
US6213965B1 (en) 1998-04-06 2001-04-10 Augustine Medical, Inc. Wound treatment apparatus with infrared absorptive wound cover
US6080189A (en) 1998-04-06 2000-06-27 Augustine Medical, Inc. Wound treatment apparatus including a heater and an IR-Transparent or IR-Transmissive bandage
US6235047B1 (en) 1998-04-06 2001-05-22 Augustine Medical, Inc. Wound treatment apparatus with a heater, a heat conductive bandage, and heat-spreading means acting between the heater and bandage
US6143945A (en) 1998-04-06 2000-11-07 Augustine Medical, Inc. Bandage for autolytic wound debridement
US6086587A (en) 1998-07-10 2000-07-11 Hawk; Rodney Multi-head suction assembly for use in surgical procedures
US6458109B1 (en) 1998-08-07 2002-10-01 Hill-Rom Services, Inc. Wound treatment apparatus
US6325788B1 (en) 1998-09-16 2001-12-04 Mckay Douglas William Treatment of wound or joint for relief of pain and promotion of healing
US7662409B2 (en) 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US6488643B1 (en) 1998-10-08 2002-12-03 Kci Licensing, Inc. Wound healing foot wrap
GB9822341D0 (en) 1998-10-13 1998-12-09 Kci Medical Ltd Negative pressure therapy using wall suction
US6284832B1 (en) 1998-10-23 2001-09-04 Pirelli Cables And Systems, Llc Crosslinked conducting polymer composite materials and method of making same
AU1133600A (en) 1998-10-29 2000-05-22 Agion Technologies, Llc Antimicrobial plastic closures for drinking containers
US6296863B1 (en) 1998-11-23 2001-10-02 Agion Technologies, Llc Antimicrobial fabric and medical graft of the fabric
US6585767B1 (en) 1998-11-23 2003-07-01 Agion Technologies, Inc. Antimicrobial suturing ring for heart valve
US6767334B1 (en) 1998-12-23 2004-07-27 Kci Licensing, Inc. Method and apparatus for wound treatment
AU2713800A (en) 1998-12-23 2000-07-31 Kci Licensing, Inc. Method and apparatus for wound treatment
AU2217900A (en) 1998-12-31 2000-07-31 Healthshield Technologies Llc Antimicrobial contact lens case
DE29924318U1 (en) 1999-01-14 2002-09-19 Fleischmann Wilhelm dressing material
US6146423A (en) 1999-01-28 2000-11-14 Implex Corporation Patella replacement apparatus
US6430427B1 (en) 1999-02-25 2002-08-06 Electronics And Telecommunications Research Institute Method for obtaining trabecular index using trabecular pattern and method for estimating bone mineral density using trabecular indices
US6284941B1 (en) 1999-03-09 2001-09-04 Craig M. Cox Bandage having a scar treatment pad for scar management and scar repair
US6355215B1 (en) 1999-03-10 2002-03-12 Implex Corp. Wear-resistant olefinic medical implant and thermal treatment container therefor
US6395007B1 (en) 1999-03-16 2002-05-28 American Osteomedix, Inc. Apparatus and method for fixation of osteoporotic bone
US6051016A (en) 1999-03-29 2000-04-18 Instrumed, Inc. System and method of controlling pressure in a surgical tourniquet
US20070014837A1 (en) 1999-04-02 2007-01-18 Kci Licensing, Inc. System and method for use of agent in combination with subatmospheric pressure tissue treatment
BR0009519A (en) 1999-04-02 2003-03-05 Kinetic Concepts Inc Process to promote wound healing in mammals
JP2004516228A (en) 1999-04-02 2004-06-03 キネティック コンセプツ インコーポレイテッド Vacuum assisted closing system with equipment for introducing the drug
US20070021697A1 (en) 2004-07-26 2007-01-25 Kci Licensing, Inc. System and method for use of agent in combination with subatmospheric tissue treatment
US7947033B2 (en) 1999-04-06 2011-05-24 Kci Licensing Inc. Systems and methods for detection of wound fluid blood and application of phototherapy in conjunction with reduced pressure wound treatment system
US6856821B2 (en) 2000-05-26 2005-02-15 Kci Licensing, Inc. System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure
US7799004B2 (en) 2001-03-05 2010-09-21 Kci Licensing, Inc. Negative pressure wound treatment apparatus and infection identification system and method
US6994702B1 (en) 1999-04-06 2006-02-07 Kci Licensing, Inc. Vacuum assisted closure pad with adaptation for phototherapy
US6695823B1 (en) 1999-04-09 2004-02-24 Kci Licensing, Inc. Wound therapy device
JP5153974B2 (en) * 1999-04-09 2013-02-27 ケーシーアイ ライセンシング インコーポレイテッド Wound treatment device
GB9909301D0 (en) 1999-04-22 1999-06-16 Kci Medical Ltd Wound treatment apparatus employing reduced pressure
US6203563B1 (en) 1999-05-26 2001-03-20 Ernesto Ramos Fernandez Healing device applied to persistent wounds, fistulas, pancreatitis, varicose ulcers, and other medical or veterinary pathologies of a patient
US6447491B1 (en) 1999-06-18 2002-09-10 Genzyme Corporation Rolling seal suction pressure regulator, apparatus and system for draining a body cavity and methods related thereto
US6306424B1 (en) 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
AU782297B2 (en) 1999-06-30 2005-07-14 Ethicon Inc. Porous tissue scaffoldings for the repair or regeneration of tissue
US6190391B1 (en) 1999-10-01 2001-02-20 Bristol-Myers Squibb Company Method of preparing a resected posterior surface of a patella to receive a prosthetic element
GB9926538D0 (en) 1999-11-09 2000-01-12 Kci Medical Ltd Multi-lumen connector
US6764462B2 (en) 2000-11-29 2004-07-20 Hill-Rom Services Inc. Wound treatment apparatus
ATE400315T1 (en) 1999-11-29 2008-07-15 Hill Rom Services Inc DEVICE FOR TREATING A WOUND
US6824533B2 (en) 2000-11-29 2004-11-30 Hill-Rom Services, Inc. Wound treatment apparatus
US6491693B1 (en) 1999-12-07 2002-12-10 Michael Lytinas Method of promoting osteogenesis by application of a vacuum to affected bone areas, and device for same
KR100343777B1 (en) 1999-12-10 2002-07-20 한국전자통신연구원 Method for calibrating trabecular index using sawtooth-shaped rack
US6528697B1 (en) 2000-01-03 2003-03-04 Augustine Medical, Inc. Modular bandage
US6641604B1 (en) 2000-02-11 2003-11-04 Iotek, Inc. Devices and method for manipulation of organ tissue
US6682491B2 (en) 2000-02-11 2004-01-27 Kci Licensing, Inc. Method for artifact reduction in intracranial pressure measurements
RU2186541C2 (en) * 2000-05-03 2002-08-10 Самарский государственный медицинский университет Method for stabilizing the mobile vertebral segment in case of surgical correction of spondilolisthesis
GB0011202D0 (en) 2000-05-09 2000-06-28 Kci Licensing Inc Abdominal wound dressing
US6485503B2 (en) 2000-05-19 2002-11-26 Coapt Systems, Inc. Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device
EP1294325B1 (en) 2000-05-22 2008-09-10 Arthur C. Coffey Combination sis and vacuum bandage
ATE520355T1 (en) 2000-06-07 2011-09-15 Aircast Inc METHOD AND DEVICE FOR SIMPLIFYING BONE Fracture Healing
US6520982B1 (en) 2000-06-08 2003-02-18 Kci Licensing, Inc. Localized liquid therapy and thermotherapy device
US6685681B2 (en) 2000-11-29 2004-02-03 Hill-Rom Services, Inc. Vacuum therapy and cleansing dressing for wounds
US6855135B2 (en) 2000-11-29 2005-02-15 Hill-Rom Services, Inc. Vacuum therapy and cleansing dressing for wounds
US20020084178A1 (en) * 2000-12-19 2002-07-04 Nicast Corporation Ltd. Method and apparatus for manufacturing polymer fiber shells via electrospinning
JP2004531292A (en) 2001-01-02 2004-10-14 アドヴァンスト セラミックス リサーチ インコーポレイテッド Biomedically applied compositions and methods
DE10102317A1 (en) 2001-01-19 2002-08-14 Hmt Ag Method and device for applying pressure waves to the body of a living being
US7070584B2 (en) 2001-02-20 2006-07-04 Kci Licensing, Inc. Biocompatible wound dressing
US7700819B2 (en) * 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US6663349B1 (en) 2001-03-02 2003-12-16 Reliance Electric Technologies, Llc System and method for controlling pump cavitation and blockage
US7108683B2 (en) 2001-04-30 2006-09-19 Kci Licensing, Inc Wound therapy and tissue management system and method with fluid differentiation
AU2002315027A1 (en) 2001-05-15 2002-11-25 Children's Medical Center Corporation Methods and apparatus for application of micro-mechanical forces to tissues
EP2204213B2 (en) 2001-07-12 2020-04-01 KCI Licensing, Inc. Control of vacuum level rate of change
CA2450683A1 (en) 2001-07-16 2003-01-30 Edwards Lifesciences Corporation Tissue engineered heart valve
US7004915B2 (en) 2001-08-24 2006-02-28 Kci Licensing, Inc. Negative pressure assisted tissue treatment system
AUPR773901A0 (en) 2001-09-18 2001-10-11 University Of Queensland, The Fracture cuff
AU2002330131A1 (en) 2001-09-28 2003-04-07 Goldberg, Eugene, P. Biopolymer and biopolymer-cell compositions for nerve tissue repair
SE524111C2 (en) 2001-09-28 2004-06-29 Jan Otto Solem A method and device for organ recovery
US20030077564A1 (en) * 2001-10-02 2003-04-24 Board Of Trustees Of Southern Illinois University Nutrient medium for maintaining neural cells in injured nervous system
US7722894B2 (en) 2001-10-22 2010-05-25 Massachusetts Institute Of Technology Biodegradable polymer
US6648862B2 (en) 2001-11-20 2003-11-18 Spheric Products, Ltd. Personally portable vacuum desiccator
US20030219469A1 (en) 2002-02-11 2003-11-27 Kci Licensing, Inc. Environmental control device for tissue treatment
US6942633B2 (en) 2002-03-22 2005-09-13 Twin Star Medical, Inc. System for treating tissue swelling
US20040225178A1 (en) 2002-05-21 2004-11-11 Kriewall Timothy J. Apparatus and methods for treating symptoms of disease and conditions of the ear
JP4558481B2 (en) * 2002-05-31 2010-10-06 ケーシーアイ メディカル リソーシーズ Wound treatment device
US20030225347A1 (en) 2002-06-03 2003-12-04 Argenta Louis C. Directed tissue growth employing reduced pressure
US7066960B1 (en) 2002-06-28 2006-06-27 Dickman Curtis A Intervertebral disk replacement
US7413571B2 (en) 2002-08-21 2008-08-19 Kci Licensing, Inc. Flexible medical closure screen and method
US7351250B2 (en) 2002-08-21 2008-04-01 Kci Licensing, Inc. Circumferential medical closure device and method
US7413570B2 (en) 2002-08-21 2008-08-19 Kci Licensing, Inc. Medical closure screen installation systems and methods
US7381211B2 (en) 2002-08-21 2008-06-03 Kci Licensing, Inc. Medical closure screen device and method
US7410495B2 (en) 2002-08-21 2008-08-12 Kci Licensing, Inc. Medical closure clip system and method
US20040039391A1 (en) 2002-08-23 2004-02-26 Argenta Louis C. Bone treatment employing reduced pressure
US20040122434A1 (en) 2002-08-23 2004-06-24 Argenta Louis C. Bone treatment employing reduced pressure
US7846141B2 (en) 2002-09-03 2010-12-07 Bluesky Medical Group Incorporated Reduced pressure treatment system
US7625362B2 (en) 2003-09-16 2009-12-01 Boehringer Technologies, L.P. Apparatus and method for suction-assisted wound healing
US7815616B2 (en) 2002-09-16 2010-10-19 Boehringer Technologies, L.P. Device for treating a wound
US6840960B2 (en) 2002-09-27 2005-01-11 Stephen K. Bubb Porous implant system and treatment method
US20060121080A1 (en) 2002-11-13 2006-06-08 Lye Whye K Medical devices having nanoporous layers and methods for making the same
US7175625B2 (en) 2002-11-25 2007-02-13 Triage Medical Soft tissue anchor and method of using same
US20040127845A1 (en) 2002-12-27 2004-07-01 Playtex Products, Inc. Breast pump system
US7976519B2 (en) 2002-12-31 2011-07-12 Kci Licensing, Inc. Externally-applied patient interface system and method
US6951553B2 (en) 2002-12-31 2005-10-04 Kci Licensing, Inc Tissue closure treatment system and method with externally-applied patient interface
US20040210009A1 (en) 2003-01-31 2004-10-21 Sadayuki Kobayashi Polymer alloy and method for manufacturing polymer alloy
US7169151B1 (en) 2003-04-10 2007-01-30 Kci Licensing, Inc. Bone regeneration device for long bones, and method of use
SG144168A1 (en) 2003-07-22 2008-07-29 Kci Licensing Inc Negative pressure wound treatment dressing
US7942866B2 (en) 2003-08-28 2011-05-17 Boehringer Technologies, L.P. Device for treating a wound
US20050065484A1 (en) 2003-09-10 2005-03-24 Watson Richard L. Wound healing apparatus with bioabsorbable material and suction tubes
DE10342071B4 (en) 2003-09-10 2006-01-19 Fleischmann, Wilhelm, Dr.med. Device and method for applying substances to a wound surface
WO2005028631A2 (en) 2003-09-19 2005-03-31 Northwestern University A novel biodegradable elastomeric scaffold for tissue engineering and light scattering fingerprinting methods for testing the same
US20090325859A1 (en) 2003-09-19 2009-12-31 Northwestern University Citric acid polymers
EP1691856A2 (en) 2003-10-14 2006-08-23 Cube Medical A/S Medical device with electrospun nanofibers
GB0325130D0 (en) 2003-10-28 2003-12-03 Smith & Nephew Apparatus with scaffold
US7887510B2 (en) 2003-12-08 2011-02-15 Boehringer Laboratories, Inc. Suction control apparatus and methods for maintaining fluid flow without compromising sterile lines
US7128735B2 (en) 2004-01-02 2006-10-31 Richard Scott Weston Reduced pressure wound treatment appliance
US7270647B2 (en) 2004-03-04 2007-09-18 Boehringer Technologies, L.P. Apparatus for vacuum-assisted irrigation and drainage of a body cavity
US8100887B2 (en) 2004-03-09 2012-01-24 Bluesky Medical Group Incorporated Enclosure-based reduced pressure treatment system
US7754937B2 (en) 2004-03-18 2010-07-13 Boehringer Technologies, L.P. Wound packing material for use with suction
US7708724B2 (en) 2004-04-05 2010-05-04 Blue Sky Medical Group Incorporated Reduced pressure wound cupping treatment system
US7909805B2 (en) 2004-04-05 2011-03-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US8062272B2 (en) 2004-05-21 2011-11-22 Bluesky Medical Group Incorporated Flexible reduced pressure treatment appliance
US7776028B2 (en) 2004-04-05 2010-08-17 Bluesky Medical Group Incorporated Adjustable overlay reduced pressure wound treatment system
US7884258B2 (en) 2004-04-13 2011-02-08 Boehringer Technologies, L.P. Wound contact device
GB0508528D0 (en) * 2005-04-27 2005-06-01 Smith & Nephew SAI with macrostress
GB0424046D0 (en) 2004-10-29 2004-12-01 Smith & Nephew Apparatus
US7998125B2 (en) 2004-05-21 2011-08-16 Bluesky Medical Group Incorporated Hypobaric chamber treatment system
NZ553254A (en) 2004-07-26 2009-10-30 Kci Licensing Inc Method for coating substrate with antimicrobial agent and product formed thereby
US8172857B2 (en) 2004-08-27 2012-05-08 Davol, Inc. Endoscopic tissue apposition device and method of use
US7485112B2 (en) 2004-11-08 2009-02-03 Boehringer Technologies, L.P. Tube attachment device for wound treatment
US20080102054A1 (en) * 2005-01-18 2008-05-01 Faustman Denise L Compositions Containing Agm Cells And Methods Of Use Thereof
US20060293169A1 (en) 2005-02-09 2006-12-28 General Electric Company Molecular structures for gas sensing and devices and methods therewith
US8048446B2 (en) 2005-05-10 2011-11-01 Drexel University Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
US8932620B2 (en) 2005-06-17 2015-01-13 Drexel University Three-dimensional scaffolds for tissue engineering made by processing complex extracts of natural extracellular matrices
US20070155010A1 (en) 2005-07-29 2007-07-05 Farnsworth Ted R Highly porous self-cohered fibrous tissue engineering scaffold
US20070032754A1 (en) 2005-08-02 2007-02-08 Walsh Richard F Method and apparatus for treating a wound
US20070071790A1 (en) * 2005-09-28 2007-03-29 Northwestern University Biodegradable nanocomposites with enhance mechanical properties for soft tissue
GB0524027D0 (en) 2005-11-25 2006-01-04 Smith & Nephew Fibrous dressing
WO2007067685A2 (en) 2005-12-06 2007-06-14 Kci Licensing Inc Wound exudate removal and isolation system
US20090011486A1 (en) 2006-01-12 2009-01-08 Massachusetts Institute Of Technology Biodegradable Elastomers
EP1988847B1 (en) 2006-02-08 2014-08-13 Northwestern University Functionalizing implantable devices with a poly (diol-co-citrate) polymer
KR101164293B1 (en) 2006-03-14 2012-07-09 케이씨아이 라이센싱 인코포레이티드 System and method for purging a reduced pressure apparatus during the administration of reduced pressure treatment
US9050402B2 (en) * 2006-03-14 2015-06-09 Kci Licensing, Inc. Method for percutaneously administering reduced pressure treatment using balloon dissection
US8974542B2 (en) 2006-06-27 2015-03-10 University of Pittsburgh—of the Commonwealth System of Higher Education Biodegradable elastomeric patch for treating cardiac or cardiovascular conditions
WO2008019126A2 (en) 2006-08-04 2008-02-14 Stb Lifesaving Technologies, Inc. Process for production of solid wound dressing
JP2008099565A (en) 2006-10-17 2008-05-01 Koken Co Ltd Sponge-like sheet for culturing cardiac muscle
US20080103489A1 (en) 2006-10-26 2008-05-01 The University Of North Carolina At Chapel Hill Vacuum adherent dressings, systems and methods of use for same
US20080112998A1 (en) 2006-11-14 2008-05-15 Hongjun Wang Innovative bottom-up cell assembly approach to three-dimensional tissue formation using nano-or micro-fibers
US7931651B2 (en) 2006-11-17 2011-04-26 Wake Lake University Health Sciences External fixation assembly and method of use
JP5433420B2 (en) 2006-12-06 2014-03-05 スパイナル・モデュレーション・インコーポレイテッド Collective lead for spinal cord stimulation
GB0625964D0 (en) * 2006-12-23 2007-02-07 Renovo Ltd Promotion of wound contraction
US8377016B2 (en) 2007-01-10 2013-02-19 Wake Forest University Health Sciences Apparatus and method for wound treatment employing periodic sub-atmospheric pressure
US20080208171A1 (en) 2007-02-23 2008-08-28 Argenta Louis C Device and method for removing edema
EP2129409B2 (en) 2007-03-14 2021-11-24 The Board of Trustees of the Leland Stanford Junior University Devices for application of reduced pressure therapy
ES2625463T3 (en) 2007-05-24 2017-07-19 Applied Tissue Technologies Llc Wound treatment device that uses negative pressure
RU70627U1 (en) 2007-09-17 2008-02-10 Вадим Владимирович Белов DEVICE FOR VACUUM THERAPY OF PURULENT RAS
US7923486B2 (en) 2007-10-04 2011-04-12 Board Of Regents, The University Of Texas System Bio-polymer and scaffold-sheet method for tissue engineering
BRPI0817544A2 (en) 2007-10-10 2017-05-02 Univ Wake Forest Health Sciences apparatus for treating damaged spinal cord tissue
WO2009089435A1 (en) 2008-01-09 2009-07-16 Wake Forest University Health Sciences Device and method for treating central nervous system pathology
WO2009103057A2 (en) 2008-02-15 2009-08-20 The General Hospital Corporation Polyglycerol sebecate peritoneal adhesion prevention barrier
US8248305B2 (en) 2008-06-03 2012-08-21 University Of Houston Antennas based on a conductive polymer composite and methods for production thereof
RU2544093C2 (en) 2008-07-18 2015-03-10 Уэйк Форест Юниверсити Хелс Сайенсиз Device and method for cardiac tissue modulation by local application of pressure below atmospheric for minimising cell death and injury
GB0816496D0 (en) 2008-09-10 2008-10-15 Zhao Xiaobin Hyaluronic acid cryogel
US20100221304A1 (en) 2009-02-26 2010-09-02 The Regents Of The University Of Colorado, A Body Corporate Bionanocomposite Materials and Methods For Producing and Using the Same
EP2421550B1 (en) 2009-04-20 2013-06-12 Allergan, Inc. Silk fibroin hydrogels and uses thereof
AU2010286604A1 (en) 2009-08-28 2012-03-08 Innovative Health Technologies, Llc Polymer adhesive film for directed cellular growth
WO2012004627A1 (en) 2010-07-09 2012-01-12 Indian Institute Of Technology Madras Nerve guide conduit containing carbon nanotubes
EP2646065A4 (en) 2010-12-05 2016-03-23 Nanonerve Inc Fibrous polymer scaffolds having diametrically patterned polymer fibers

Also Published As

Publication number Publication date
US20200384168A1 (en) 2020-12-10
BRPI0817544A2 (en) 2017-05-02
ZA201002498B (en) 2011-01-26
US20090187259A1 (en) 2009-07-23
KR20100100798A (en) 2010-09-15
RU2010118021A (en) 2011-11-20
JP2011500163A (en) 2011-01-06
JP5462175B2 (en) 2014-04-02
CA2702239A1 (en) 2009-04-16
IL204825A0 (en) 2010-11-30
EP2205189A1 (en) 2010-07-14
AU2008310819A1 (en) 2009-04-16
AU2008310819B2 (en) 2013-06-27
ES2661762T3 (en) 2018-04-03
US8834520B2 (en) 2014-09-16
CA2702239C (en) 2016-11-08
US20170368242A1 (en) 2017-12-28
WO2009049058A1 (en) 2009-04-16
US10632235B2 (en) 2020-04-28
RU2489993C2 (en) 2013-08-20
EP2205189A4 (en) 2015-08-26
US20140350499A1 (en) 2014-11-27
HK1150958A1 (en) 2012-01-20
DK2205189T3 (en) 2018-03-12
IL204825A (en) 2014-04-30
EP2205189B1 (en) 2017-12-06
CN101896140A (en) 2010-11-24
KR101600041B1 (en) 2016-03-03

Similar Documents

Publication Publication Date Title
CN101896140B (en) Devices and methods for treating spinal cord tissue
RU2517588C2 (en) Device and method for treating pathologies of central nervous system
KR102129562B1 (en) Method and composition for treating inflammatory bowel disease without colectomy
US9655948B1 (en) Non-surgical, localized delivery of compositions for placental growth factors
Moreland Collection and withdrawal of body fluids and infusion techniques
Shahar et al. A technique for management of bite wounds of the thoracic wall in small dogs
Janicek et al. Hindlimb kinematics before and after laser fibrotomy in horses with fibrotic myopathy
CN104368043B (en) A kind of collagen stroma repair of cartilage film, preparation method and application
Lacasse Falconiformes (falcons, hawks, eagles, kites, harriers, buzzards, ospreys, caracaras, secretary birds, Old World and New World vultures)
CN101020049A (en) Use of ulinastatin in preparing medicine for treating and/or preventing spinal cord injury
CN105363073A (en) Tissue engineering cartilage stent containing bioactive factor as well as preparation method and application of tissue engineering cartilage stent
Vogelnest Capture, physical and chemical restraint
WO2015157027A1 (en) Fibrous component for health, performance, and aesthetic treatment
AU2013202873B2 (en) Devices and methods for treating spinal cord tissue
Malyuk et al. Influence of autological growth factors on activation of regenerative processes of the superficial digital flexor tendon of horses
Esterowitz et al. Plantar warts in the athlete
Park et al. Treatment of bilateral corneal ulceration in a Peregrine Falcon (Falco peregrinus) using 360 degree conjunctival flaps
Dijk Pilot study to test attachment of repair tissue to a non-resorbable osteochondral implant with vertical channels
Lamas et al. Desmectomy of a septic accessory ligament of the deep digital flexor tendon in the hindlimb of a horse under standing sedation
KR19990037907A (en) Acupuncture therapy of sow mastitis by honeybee venom
Robinson et al. The use of a chitosan-based hyaluronate gel in musculoskeletal afflictions
Hopper Treatment Options for Hindlimb Proximal Suspensory Desmitis
Clark Studies on the physiology of the reticulum and rumen
CN103505301A (en) Rat spinal cord full-transection injury model and method for establishing rat spinal cord full-transection damage model

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1150958

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140108

Termination date: 20151009

EXPY Termination of patent right or utility model